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The Synaptonemal Complex Protein 3 (SYCP3), a key component of the synaptonemal
complex in mammalian meiosis, has many closely related X‐linked homologs on the X
chromosome of which the functions are unclear. In rodentia, these genes comprise the Xlr
superfamily of proteins and studies elucidating spatial and temporal profiles of these homologs
reveal primarily testis specific function. The following study provides evidence for murine testis
and ovary function of a newly discovered Xlr superfamily protein, X‐linked Lymphocyte
Regulated 3 (XLR3). In addition to showing the immunolocalization of the XLR3 protein at the
condensed X and Y chromosomes throughout Meiotic Sex Chromosome Inactivation (MSCI),
preliminary experiments behind the mechanism controlling expression of the imprinted
Xlr3b/4b/4c copies reveals a differentially methylated region (DMR) in the adjacent single copy
Factor 8 associated gene A (F8a) consistent with differential binding of the master regulator of
chromatin conformation factor CTCF.
Additionally, this work also aims to provide the groundwork for deletion of XLR3 from
meiosis to assess its significance in meiotic drive theory, sex chromosome conflict, and
infertility. Two similar Xlr superfamily genes, SLX and SLY, whose absence causes near sterility
and litter gender bias, have been shown to control gene expression emanating from the sex
chromosomes specifically during meiosis. Uncovering the function of these rapidly evolving
superfamily proteins in the transmission of the sex chromosomes will add to the growing

evidence for a mammalian sex chromosome conflict model of inheritance involving additional
layers of gene regulation.
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Chapter 1: Introduction

Overview
Meiosis is a unifying process among sexual reproducing organisms involving the
maturation of progenitor germ cells into haploid gametes for reproduction. Meiosis is divided
into two parts; Meiosis I marks a dynamic transformation in germ cell DNA where homologous
chromosomes replicate, condense, pair, synapse, recombine and segregate, and Meiosis II
which provides a second and necessary segregation of the diploid genome into haploid
gametes.1
One of the most important and best characterized aspects of meiosis occurs during the
pairing, synapse, and recombining of DNA (maternal and paternal genomes) to ultimately
contribute to variation seen within species. The effort of organizing the DNA is accomplished
through a tightly coordinated proteinaceous complex known as the synaptonemal complex (SC)
which aligns homologous chromosomes along an axis in preparation for recombination.2
Necessary to this scaffold is the synaptonemal complex protein 3 (SYCP3) which is an
autosomally located gene that has evolved many X‐linked duplicons on the mammalian X.3
SYCP3 duplicons comprise a gene family that is defined by the presence of the COR1 domain,
and are termed X‐linked Lymphocyte Regulated (Xlr) superfamily genes. Recent studies in
mouse reveal that many of these genes play a role in meiosis and the majority have testis‐
specific expression profiles (SLY, SLX, SLXL1, XLR6/SLX2); however, their functions and relation
to SYCP3 remains somewhat unclear.4–7 Another cluster of X‐linked SYCP3 duplicons (Xlr3, Xlr4,
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and Xlr5) located at XA7.2 were shown to have imprinted expression in neonatal mouse brain.8
This study aimed to determine protein functionality of the multicopy gene, Xlr3, and elucidate
its mechanism of imprinting through three specific aims:
1) Determine whether the Xlr3 gene produces a functional protein and elucidate the
XLR3 spatial and temporal profile in mouse through immune‐fluorescent labeling.
2) Generate an Xlr3 knockdown mouse model to determine whether XLR3, like SYCP3,
is necessary for meiosis.
3) Identify and characterize the imprinting control region (ICR) regulating
imprinted expression at Xlr3b/4b/4c.
The following body of work provides evidence for the existence of XLR3 as a highly
regulated meiotic protein, which localizes to the inactive XY body in meiotic spermatocytes and
to nucleolus organizer regions (NORs) in oocytes. This work also suggests that a hypothetical
function of XLR3 may involve, through structural means, global or local activation or repression
of the sex chromosomes, implicating XLR3 in meiotic drive theory and sex chromosome conflict.
Evidence is also presented of a differentially methylated region (DMR) in a gene adjacent to the
imprinted Xlr paralogs, termed F8a, which displays differential methylation and CTCF occupancy
between maternal and paternal alleles that may constitute the Imprinting Control Region (ICR).
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Germ Cells in Mammals
In contrast to Drosophila and C. elegans, where the preformed germplasm gives rise to
germ cells, the laboratory mouse, Mus musculus, germ cells form through induction by which
any cell in the blastocyst can become part of the germ line. At embryonic day 6.25 (E6.25)
mouse embryos express the earliest known marker to indicate germ cell development, PR
containing domain 1 (Prdm1), which can be detected in only about six cells in the posterior
epiblast.1 WNT3 signaling induces competency of these cells to bone morphogenic protein 4
(BMP4) creating a germ cell "precursor" state. The subsequently formed primordial germ cells
(PGCs) must initially travel through the gut of the developing embryo while replicating and
resisting differentiating factors from the surrounding region until they reach the developing
gonad. Germ cells accomplish stability throughout this migration with high expression of the
pluripotency factors Octamer binding protein 4 (Oct4), Nanog Homeobox (Nanog), and SRY‐box
containing gene 2 (Sox2).
Development of the PGCs into oocytes or spermatogonia is dependent on cues from the
gonads, which initially develop as female by default. In the early female gonad (E12) retinoic
acid and Deleted in azoospermia‐like (Dazl) signal Stimulated by retinoic acid 8 (Stra8) to initiate
meiosis causing the PGCs to develop into oocytes.9 The male gonad inhibits the effects of
retinoic acid with CYP26b1 which is expressed from fetal sertoli cells, and instead male
differentiation factors such as Nanos2 and Dnmt3l are expressed. This sexually dimorphic event
thrusts female mouse embryos into meiosis at E13 while male mice initiate meiosis much later
when CYP26b1 is repressed around 6 days post‐partum (dpp). It should be noted that Stra8
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induction and, ultimately, male/female germ cell commitment, is thought to depend on the
ratio of retinoic acid and male differentiating Fibroblast growth factor 9 (Fgf9).10,11
Meiosis (General)
Meiosis allows for genetic variation in offspring by recombining DNA while accounting
for the proper chromosomal ploidy needed for sexual reproduction.1 In 6 day old male mice,
the precursor germ cell state, termed “Type A” spermatogonia, replicate to form a constant
supply of Type A spermatogonia as well as “Type B” spermatogonia.12 Type B spermatogonia
develop into primary spermatocytes and undergo chromosomal replication increasing the
genome size from 2n to 4n. Chromosomes in the primary spermatocyte then dynamically
condense during the first stage of prophase I, allowing them to begin pairing with homologs.
Once paired, non‐sister chromatids of homologous chromosomes form chiasmata, or
attachment points, and begin homologous recombination between maternal and paternal
genomes.2 Chromosomes in prophase I align in a highly coordinated fashion by an essential
proteinaceous complex termed the Synaptonemal Complex (SC).2,13–15 The role of this structure
is to mediate chromosomal crossover events during prophase I. After crossover events occur
chromosomes remain attached by chiasmata and "relax" allowing a slight increase in
transcription. In females, meiosis arrests in prophase I after crossover events until cued to
continue division after birth. The last substage of prophase I is indicated by nuclear membrane
disintegration along with meiotic spindle formation. Reduction through metaphase I, anaphase
I, and telophase I results in breaking of chiasmata and the newly diploid genome is further
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reduced to a haploid genome in meiosis II, where reduction occurs similarly to mitosis. The
resulting haploid germ cells mature into gametes as ova or mature sperm.
Meiotic Prophase Events and the Synaptonemal Complex
When primary spermatocytes initiate meiosis, DNA replicates during interphase I in
order to prepare homologous chromosomes for recombination during prophase I. The initiator
protein SPO11, an ancient topoisomerase‐like enzyme, induces double‐stranded breaks (DSBs)
globally which has been shown to be necessary for downstream recombination events to occur.
Spo11‐/‐ mice arrest at prophase due to a lack in accumulation of DSBs and DNA repair protein
RAD51, ultimately abolishing the synapsis of homologs.16,17 In anticipation of induced DSBs via
SPO11, the synaptonemal complex (SC) begins to form as a result of an ataxia telangiectasia
and Rad3 related (ATR) phosphorylation cascade event.
Figure 1 displays the complete scaffold of the synaptonemal complex and core elements
involved. During the first stage of prophase I, leptotene or leptonema (“Thin Threads”), the
"Lateral elements (LEs)" are the first SC proteins to form between each parental chromosome
and are comprised of SYCP2 and SYCP3 fiber polymers.2,18 These two proteins have been shown
to self‐assemble homo‐ and hetero‐dimers with each other to create short fibers in‐vitro, likely
through use of C‐terminal coiled coil motifs.19,20 Chromatin at this stage dynamically condenses
down and associates with the LEs in a loop structure that is not yet well understood.
SYCP2/SYCP3 loss of function studies have shown meiosis to fail at this stage due to improper
assembly of the lateral elements and impairment of chromatin synapsis.21,22
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Zygonema or zygotene (“Paired Threads”), the second stage of prophase, marks
assembly of the "transverse filaments (TF)" and the "central elements (CE)" which allows the
LEs to come together in a zipper‐like fashion known as "synapsis." Chromosomes are therefore
dynamically aligned with homologs along an axis poised for recombination.

Figure 1. EM and illustration provided by M. Westergaard and D. Von Wettstein of how the
synaptonemal complex is structured into three regions relative to chromatin.23

Pachynema or pachytene (“Thick Threads”), marks the longest stage in meiosis lasting three
days in mice. At this stage, synapsis of homologous chromosomes through the SC is complete
leaving a stable intermediate structure allowing for recombination events to occur (see Figure 2
below). Recombination proteins RAD51 and DMC1 aggregate at ~300 specific regions at the LEs
to produce early recombination nodules (ENs) visible through immuno‐staining.2,24 These sites
are apparent even before complete SC synapsis, however, they are not thought to be
undergoing recombination early in pachytene. The ENs shift to an intermediate state known as
transition nodules (TNs) indicated by recruitment of stabilizing and DNA repair proteins RPA,
BLM, MSH4 and MSH5. While these proteins mediate a connection between both LEs,
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recombination won't occur until MLH1 is recruited. MLH1 is paramount to class I crossover
events which only occurs in ~25 of the initial 300 early nodules. In this sense, recombination
crossover events occur about once or twice per SC ‐ these mature crossovers are known as late
recombination nodules (RN). The TNs that are not destined to crossover are dislocated from
each other and associate back with the rest of the SC as non‐crossover events. It should be
noted that some sites of recombination occur even when MLH1 has not been recruited, and
these are referred as to class II crossover events.
Additionally during pachytene in males, the X and Y chromosomes are transcriptionally
inactivated and packaged into a separate nuclear compartment known as the “XY body” or
"sex‐body." This phenomenon is known as meiotic sex chromosome inactivation (MSCI) and is
part of a more general mechanism known as meiotic silencing of unsynapsed chromatin
(MSUC).25 The X and Y synapse exclusively at the pseudoautosomal regions (PARs) but lack of
homology elsewhere activates MSUC. This is thought to occur to prevent aneuploidies which
may result due to the cells’ failure to recognize the unsynapsed XY during meiosis, but
additional theories for existence of this mechanism stem back to Fischer (1931) and Rice
(1984).25 They predicted that many of the genes on the sex chromosomes are sexually
antagonistic and, due to the hemizygous nature of the X chromosome in males, genes are
immediately selected for if they are advantageous to male reproduction. In fact, a
disproportionate amount of genes with roles in spermatogenesis are found on the murine X
and the Y chromsomes.26,27 It is thought that, if allowed to express during meiosis, these genes
may distort the inheritance of the sex chromosomes and thus a global silencing of both
chromosomes is key.28
7

Perhaps the most important factor necessary to development of the XY body is the
histone variant H2AX which becomes phosphorylated upon induction of global DSBs by
SPO11.25 This variant is also activated in response to somatic cell DSBs and once
phosphorylated it is termed γH2AX. In meiosis, H2AX is activated in two waves, first localizing in
response to SPO11 induced DSBs globally in the nucleus and secondly to chromatin of the X and
Y during MSCI. In H2AX‐/‐ male mice spermatogenesis fails in pachytene due to failed MSCI, a
necessity for proper spermatogenesis.29 The exact function of this histone modification has yet
to be elucidated but it is seen at DNA at class I crossover events and is known to recruit a
mediator of DNA damage checkpoint protein MDC1.30 H2AX is phosphorylated by ATR (ataxia
telangiectasia and Rad3 related), a PI3‐like kinase similar to ATM (ataxia telangietasia
mutant).16 ATR is surprisingly recruited by BRCA1 and is seen localizing with BRCA1 at the XY
body until dephosphorylation of γH2AX in early diplotene. It is therefore no surprise that BRCA1
deficient mutant mice fail to phosphorylate H2AX resulting in meiotic arrest.25,31,32
Epigenetically speaking, γH2AX, ATR, and BRCA1 are necessary for numerous downstream
silencing marks on the sex chromosomes such as H2A ubiquitylation, H3K9me2, and
deacetylation of H3 and H4.25
While a large amount of evidence supports that the genome in prophase I of meiosis is
active and the X and Y are actively silenced, Page et al. (2012) conversely proposed that
transcription is low genome‐wide and is then activated in the early stages of prophase I except
at the inactive X and Y.33
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The three previously discussed stages of prophase I mark formation and primary
function of the SC, which won't serve any post‐meiotic function. Below are SYCP3 fluorescently
labelled spermatocytes showing formation and later degradation of the SC.

diakinesis

Figure 2. The Synaptonemal Complex via SYCP3 Staining. Fluorescently labelled SYCP3 allows
for staging of the SC in primary spermatocytes. Leptotene, Zygotene, and Pachytene represent
formation of the SC while Diplotene and Diakinesis mark degradation of the SC. Figure adapted
from SC staining by Herr’an, Y. et al.34
Following completion of pachytene the SC begins to degrade allowing for desynapsis of
homologous chromosomes to prepare for segregation. In contrast to male mice, females
undergo these initial stages of prophase I during gestation at embryonic day 13 (E13) and arrest
in meiosis at diplotene around birth (~E20/P0), also termed dictyate (“Two Threads”). This finite
amount of halted oocytes will selectively resume meiosis starting within the first month of post‐
natal mouse maturity. Conversely, male mice will continue meiosis after diplotene and enter
9

the final stage of prophase I known as diakinesis (“Moving Through”). At this stage,
chromosomes condense further and await segregation via metaphase I. Male mice don't begin
meiosis until ~6dpp, but continually cycle this process after the first wave is complete at
18.5dpp.35 Interestingly, the synaptonemal complex shows a dimorphism between male and
female mice, having far less serious phenotypes in SC protein deficient oocytes than
spermatocytes.18
To date seven basic components of the mammalian SC have been identified. The lateral
elements are composed of SYCP2 and SYCP3, the transverse filaments (TF) are exclusively
composed of SYCP1, and the central elements are composed of SYCE1, SYCE2, SYCE3 and
Tex12.2 Additional protein components, however, are needed to adhere sister chromatids from
S phase through segregation. The proteins responsible to ensure this fidelity are known as
Cohesin Complex (CC) proteins and have a structural maintenance of chromosome (SMC)
domain which acts in organizing DNA.36 This complex acts as a clamp around chromatin and
involves two core subunits, SMC1 and SMC3, which interact with each other to make up the
main "hinge" structure of the complex. The ATPase heads of these proteins are then connected
through SCC1, a bridge kleisin protein, to form a stable clamp.37 This SCC1 component is
cleaved during metaphase to allow chromosomal segregation to occur.34 In addition to mitosis
cohesin factors SMC1α, SMC3, and RAD21, there have been four meiosis specific cohesin
subunits identified; REC8, RAD21L, SMC1β, and STAG318,34. The cohesin complex has
additionally been shown to be necessary for proper SYCP2 and SYCP3 localization and is
thought to interact with the lateral elements.18
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More recently, a group of meiotic "surveillance" factors, termed HORMA (Hop1, Rev7,
and Mad2) proteins, were discovered in mouse. These proteins were initially identified in yeast
(Hop1) and are thought to act as a meiotic pachytene checkpoint system to ensure the fidelity
of chromosomal ploidy. Hop1 is additionally responsible for ensuring that homologs recombine
rather than sister chromatids. Fukuda et al. identified HORMAD1 in mice, which
immunolocalizes to the SC at points which have yet to synapse.38–40 This signal is void once
synapsis is complete, but re‐localizes at the beginning of diplotene to regions of desynapsis.
Deficiency in another HORMA protein, HORMAD2, results in lack of ATR accumulation and
results in defects related to homolog pairing.41 It is therefore now clear that HORMA domain
proteins monitor and localize to unsynapsed regions during pachytene to prevent mistakes that
result in aneuploidies.
The Synaptonemal Complex Protein 3 (SYCP3)
The synaptonemal complex protein 3 (SYCP3) is a 254aa protein in mouse that works by
polymerizing to itself and SYCP2 to form the lateral elements of the SC at the beginning of the
leptotene stage of meiotic prophase I. In yeast, Hop1 and Red1, serve as lateral element
proteins in yeast; however, no structural similarities exist in comparison to mammalian
SYCP2/3.42 SYCP3 is highly conserved in Mammalia, containing a central α‐helix domain along
with two flanking non‐helical domains.19,20 The α‐helix contains many coiled coil motifs, which
are thought to promote homotypic interactions. Coiled‐coil domain proteins are characterized
by rigid and fibrous structures that interact with intermediate filaments (IF) creating a physical
cellular network. In fact, SYCP3 looks very similar to IFs whose coiled coil domains functions
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through dimerization while two flanking non‐helical domains contribute to lateral and
longitudinal assembly.20 While knockout studies are currently underway for these specific
domains, male meiocytes deficient in SYCP3 arrest at zygotene/pachytene due to lack of a SC.
Interestingly, female meiocytes deficient in SYCP3 were still able to form core units of the SC
and remarkably remained somewhat fertile further exemplifying the sexual dimorphism of the
SC.18,22
The X‐linked Lymphocyte Regulated (Xlr) Superfamily
SYCP3 is located on chromosome 10 in mouse, but has generated many X‐linked
duplicons on the mammalian X. In rodents, these duplicons are termed X‐linked lymphocyte
regulated (Xlr) superfamily genes due to the foundation member, Xlr, having high expression in
B‐ and T‐lymphocytes.43,44 It was first thought that the majority of these copies were
pseudogenes; however, it is now clear that many duplicons code for functional proteins, of
which a disproportionate amount have roles in spermatogenesis.26,44
The foundational member, X‐linked lymphocyte regulated (Xlr) was initially discovered in
1985 when Cohen et al. isolated a dozen highly expressed cDNAs from B and T lymphocytes to
determine whether any hybridize to the X chromosome. Since many lymphocyte maturation
defects map to genes on the X chromosome in other mammals, Cohen proposed that the one
cDNA he saw hybridizing to the X chromosome, X‐linked Lymphocyte Regulated (Xlr), may have
a role in immunodeficiency disorders.45–47 It was not until 2002 that the XLR protein was shown
to have a role in mouse oocytes leaving its high expression in B and T lymphocytes a mystery.
Since the initial discovery of Xlr, hundreds of copies of very similar looking genes have been
12

identified on the X and Y chromosomes.44 On the murine X these genes cluster to regions
known as Xlr1 and Xlr2 based on their cytogenetic location.3 While it is not known if all these Xlr
superfamily genes code a functional protein, a handful have recently been elucidated in mouse.
Transcription of two multicopy Xlr superfamily genes, Sycp3‐like X‐linked (slx) and Slx‐
like1 (slxl1), become upregulated in male post‐meiotic germ cells and code for proteins which
localize to compartments in the cytoplasm of round spermatids.3,5,35 The Y chromosome
counterpart, Sycp3‐like Y‐linked (Sly), which is upregulated around the same time, also codes a
protein that is predominately cytoplasmic in post‐meiotic germ cells, but some of which is
imported into the nucleus and localizes to the X and Y chromosomes (see Figure 3 below).48
Abolishing SLY from spermatogenesis reveals de‐repression of the X and Y chromosomes at
specific genes including Slx and Slxl1.4 In fact, SLX and SLXL1 localize to the X and Y in post‐
meiotic spermatids in the absence of SLY. This observation is suggestive of antagonistic
functions for the SLX and SLY proteins and provides a genetic basis for post‐meiotic X and Y
chromosomal intergenomic conflict that may point to a general function of all Xlr superfamily
proteins. This conflict hypothesis is bolstered by the fact that Sly deficient mice generate litters
with sex ratios favoring females, while Slx/Slxl1 deficient mice generate litters with sex ratios
favoring males. Remarkably, deficiencies in both genes recovers a 1:1 litter sex ratios.28
Ultimately, it is thought that Slx and Slxl1 are distorters of X chromosome inheritance, acting as
selfish elements to increase X chromosome inheritance. Sly is thought to be a repressor of
distortion, which is exemplified by its repressive role on the Slx, Slxl1, and the X and Y in general
(discussed further in Chapter 3).

13

Meiosis I
Meiosis II

Haploid Gametes/Round Spermatids

Figure 3. SLY Localization in Post‐Meiotic Round Spermatids. Displays the localization of the Xlr
Superfamily protein SLY to the X chromosome in X‐bearing round spermatids and to the Y
chromosome in Y‐bearing round spermatids. Figure adapted from NIH’s image and video
gallery. http://images.nigms.nih.gov/index.cfm?event=viewDetail&imageID=2546

The most recent Xlr superfamily protein elucidated, Xlr6/Slx2 (single copy), has been
shown to localize separate from Slx/Sly to the inactive XY body in pachytene of male meiosis,
the significance of which is not known.6,7 From a global view, the spatial and temporal profiles
of these Xlr superfamily genes are very much like their ancestor, SYCP3, in that they are up‐
regulated in the male germ line almost exclusively; however, each appears to have a slightly
different local meiotic profile.
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The X‐linked Lymphocyte Regulated (Xlr) Locus
Other than the XLR1 and XLR2 cytogenetic loci, an additional cluster of Xlr superfamily
genes were discovered at XA7.2 termed, Xlr3, Xlr4, and Xlr5. This locus is comprised of fifteen
Xlr superfamily genes that share extremely high sequence similarity to one another due to the
fact that they are the result of Xlr3, Xlr4, and Xlr5 duplication events (Figure 4). These
duplications have created paralogs which are arranged into triads (a, b, c, d, e), each one having
a single copy of Xlr3, Xlr4, and Xlr5 (d and e triads not shown).

Figure 4. Illustration of the X‐linked Lymphocyte Regulated (Xlr) locus at XA7.2 (mm10).
In 2005, Raefski and O'Neill showed imprinting of some of these genes in neonatal
mouse whole brain and fibroblast (C57BL/6J).8 The imprinted paralogs (shown in blue in Figure
4) cluster within the b and c triads and display maternal specific expression. Interestingly, a
biallelically expressed gene Factor 8‐associated gene A (F8a) sits in between the imprinted
paralogs. Studies aimed at elucidating the imprinting mechanism controlling these three genes
were carried out in Dr. Michael O'Neill's laboratory at the University of Connecticut by Dr.
Michael Murphy, Dr. Seth Kasowitz, Dr. Ben Carone, and Dr. Sohaib Qureshi. These previous
studies revealed co‐transcriptional stalling of RNA polymerase II exclusively on the paternal
allele of the imprinted paralogs. Further experiments aimed at revealing differential enrichment
of histone modifications showed allelic differences in H3K36me3, a mark for elongating RNA
PolII. This is likely a downstream consequence of the controlling elements regulating this locus.
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Further experiments focusing on gene regulation at this locus are discussed in Chapter 5, “Allele
Specific Differences at the Imprinted Xlr3/4/5 Locus”.
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Chapter 2: Characterization of the X‐linked Lymphocyte Regulated 3 (XLR3)
Protein

The existence of protein products and their potential function is currently not known for
any of the Xlr3/4/5 genes, including the imprinted paralogs (Xlr3b, Xlr4b, and Xlr4c). In the
“Epigenetics” chapter of this thesis it is revealed that certain autosomal loci are imprinted to
maintain protein dosages necessary for proper embryo developmental. In the case of
reciprocally imprinted Igf2/H19 on chromosome 7 in mouse, the expression of a single allele of
the potent mitogenic factor insulin‐like growth factor 2 (Igf2) is absolutely necessary for proper
embryo development and therefore the reason for its imprinted expression can be easily
understood in light of its protein function. In order to gain an understanding of why the Xlr3b
copy is imprinted, this chapter aims at identifying its protein product and shedding light on its
function. Additionally, elucidating XLR3 protein function may give insight into the underlying
evolutionary cause of the massive Xlr Superfamily expansion on the mammalian X
chromosome.

XLR3 Has Similarities to SYCP3
Due to high sequence similarities, Xlr3a/b/c were assayed together throughout this
study and henceforth will be referred to as Xlr3. The Xlr3 amino acid sequence is 226 amino
acids in length harboring a COR1 domain which extends nearly the entire length of the protein
categorizing it as a member of the Xlr Superfamily along with other meiotic proteins XLR,
SLX/XMR, SLX2/XLR6, SLY and SYCP3. In fact, the XLR3 COR1 peptide has 32% sequence identity
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with SYCP3 and at least 12% identity with all other known superfamily members (Figure 5). The
exact function of the COR1 domain is not known, though it is thought to interact with other
COR1 domain containing proteins. Additionally, the N‐terminus of XLR3 contains a canonical
monopartite nuclear localization signal (KRKR), which is not well conserved among other
superfamily proteins.

Figure 5. Protein Alignment of the Xlr Superfamily. Amino acid identity from full length Xlr
Superfamily proteins broken up into N‐terminus, Cor1, and C‐terminus domains relative to
XLR3.

Xlr3 Becomes Up‐Regulated During Spermatogenesis
Five Xlr3 paralogs are found across 2 genetic loci on the mouse X‐chromosome (Xlr3a,
Xlr3b, Xlr3c, Xlr3d and Xlr3e) each holding >97% mRNA sequence homology to each other
(Figure 6A and B). The latter two paralogs are silent pseudogenes however Xlr3a/b/c retain an
open reading frame and all potentially code for the same functional protein.
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Figure 6. Paralogous nature of Xlr3. A.) Genomic coordinates and relative positioning of
Xlr3/a/b/c/d/e paralogs. B.) Nucleotide and protein sequence identity matrix displaying high
homology among the Xlr3 paralogs.
Xlr3 transcripts were analyzed for relative expression in various tissues via qRT‐PCR
using primers common to all 3 active paralogs. Consistent with the expression status of other
Xlr superfamily genes, Xlr3, shows high relative expression in mature adult testis (Figure 7A). In
mice, the maturation of germ cell subtypes coincide closely with specific time points during
prepubertal mouse development. In order to characterize Xlr3 expression in mature testis,
transcripts were additionally analyzed at time points during postnatal male gonad
development. Testis sample collections from 6dpp through 18.5dpp encompass the first wave
of spermatogenesis during which all Xlr superfamily genes become up regulated at various
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points. Xlr3 shows a 4‐fold up regulation from 6 days post‐partum (dpp) to 18.5dpp,
encompassing maturation of the first wave of mature spermatids (Figure 7B). Basal expression
of Xlr3 is apparent in the pre‐meiotic stages, however, from 7.5dpp to 10.5dpp expression is
doubled indicating potential pre‐leptotene/leptotene protein function (~10dpp). This
expression status matches more closely to SYCP3 and XLR6/SLX2 as opposed to SLX and SLY
which are up‐regulated post‐meiotically. To further elucidate this meiotic function an antibody
was generated against the Xlr3 amino acid sequence.

Figure 7. Real‐time quantitative RTPCR analysis of Xlr3. A.) Relative expression of Xlr3 in various
tissues, normalized to Actb. B.) Relative expression of Xlr3 throughout the first wave of mature
mouse spermatogenesis. Error bars display 95% confidence intervals.
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XLR3 is a Nuclear Protein First Present at Leptotene
A custom antibody was raised against the first 18 amino acids of the N‐terminus of
XLR3A/B/C peptide sequences, which holds no homology to any other Xlr superfamily protein.
The anti‐XLR3 antibody was used to probe western blots of cytoplasmic and nuclear fractions
from adult mouse tissues. A single band consistent with the putative protein size (26.1kDa) is
detected exclusively in the nuclear fraction of the testis sample confirming translation of these
paralogs (Figure 8A). Next, post‐natal testis samples were collected, fractionated, and protein
was extracted from time points encompassing the first wave of spermatogenesis (Figure 8B).
Western blots probed with anti‐XLR3 reveal a band first present in the nuclear fraction at
10.5dpp concurrent with maturation of spermatogonia into pre‐leptotene/leptotene stage
spermatocytes (meiosis ‐ prophase I). Additional probing with anti‐γH2AX, a control for double
stranded breaks during leptotene, appears in large amounts at 10.5dpp. In order to visual the
localization of XLR3 at leptotene and stages after, immunohistochemistry was conducted on
mature adult spermatocytes.
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Figure 8. Western blot analysis of XLR3 protein. A.) Displays nuclear and cytoplasmic extracts
collected from various tissues and probed with anti‐XLR3. Positive signal is seen in the nuclear
fraction of testis relative to negative control pre‐immune sera. B.) Displays nuclear and
cytoplasmic testis extracts collected early in the first wave of mouse spermatogenesis probed
with anti‐XLR3. Alpha‐tubulin is a control for proper cytoplasm separation while gH2AX
confirms proper nuclear separation as well as the beginning of leptotene I of meiosis I.

XLR3 Associates with the XY body During Meiosis I
Fixed meiotic spermatocyte spreads were probed with anti‐SYCP3 and anti‐XLR3 and
coupled with immunofluorescence in order to visually assess XLR3 protein localization at all
stages of germ cell maturation (Figure 9). Anti‐XLR3 immunolocalizes diffusely at leptotene
agreeing with the mRNA expression increase and presence of a protein band first seen at
10.5dpp on the western. A key characteristic of male meiosis is the transcriptional inactivation
of the sex chromosomes (XY body) in a separate nuclear compartment throughout the next two
stages; zygotene and pachytene, termed Meiotic Sex Chromosome Inactivation (MSCI). XLR3
signal is next detected at the inactivated XY body first at zygotene and lasting throughout
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pachytene, confirmed through γH2AX staining, also a marker for XY body formation. In fact, this
XLR3 signal is seen closely mirroring SYCP3 at the inactive XY indicating a potential interaction
with the Synaptonemal Complex (SC).
A more in‐depth look at early, mid, and late pachytene spermatocytes (Figure 10) shows
early diffuse XLR3 signal at the XY body becoming more intimately localized with SYCP3 until it
is finally seen in late pachytene exclusively at the Synaptonemal Complex of the XY body. This
specific localization is new to Xlr superfamily proteins and suggests XLR3 has a transient role in
SC formation at the inactive XY.
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Figure 9. Immmunohistochemical Analysis of XLR3 on Meiotic Spermatocyte Spreads. Meiosis I
stages are labelled relative to SYCP3 staining. XLR3 signal appears in green and DAPI stains DNA
blue. The bottom panel shows gH2AX stained in red confirming XY body localization of XLR3.
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Pachytene Spermatocytes

Figure 10. Immunohistochemical Staining of SYCP3 and XLR3 on Pachytene Stage
Spermatocytes. A refined look at sex‐body localization of XLR3 at early, mid, and late
pachytene. Note: XLR3 staining in late pachytene localizes with the lateral elements at the
inactive XY.

XLR3 Relocalizes to Post‐Meiotic Sex Chromatin (PMSC)
To determine whether XLR3 plays a role after MSCI, immunofluorescence was
conducted on similar spermatocyte spreads containing post‐meiotic spermatids. After meiosis
I/II the X and Y chromosomes are independent of each other, one per haploid round spermatid,
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and additionally there is a slight de‐repression of the X and Y chromosomes which is termed
Post‐Meiotic Sex Chromatin (PMSC). The X and Y chromosomes at this stage tend to localize
adjacent to the nucleolus which is consistent with XLR3 immunostaining (Figure 11). This result
is also consistent with persistent Xlr3 mRNA expression through to the end of the first wave of
spermatogenesis at 18.5dpp. Co‐staining with X and Y chromosome paints and anti‐XLR3 on
round spermatids reveals co‐localization of the two signals which is later absent in mature
spermatids. As discussed earlier, two other Xlr superfamily proteins, SLX and SLY, have the
same post‐meiotic localization to PMSC and have additionally been implicated in helping to
repress certain genes on these chromosomes. It is thought that SLX and SLY may be part of an
inter‐genomic conflict mechanism at this stage, a phenomenon that XLR3 itself may have a role
in.
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Figure 11. Immunohistochemical Staining in Post‐Meiotic Spermatids. XLR3 localization in round
spermatids and mature spermatids. X and Y whole chromosome paints are both labelled green
in the bottom panels ‐ XLR3 is labelled in red.

XLR3 Localizes to Nucleolus Organizer Regions (NORs) in Oocytes
Some but not all Xlr superfamily proteins are expressed during oogenesis. The
localization of XLR3 to the sex chromosomes during MSCI and PMSC during male meiosis
prompts the investigation of the protein in female meiosis, which lacks these two mechanisms.
In order to determine whether XLR3 has a function in female meiosis, meiotic oocyte spreads
were made from embryonic ovaries representing all stages of oocyte maturation up until
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dictyate. Oocyte spreads were probed with anti‐SYCP3 and anti‐XLR3 revealing a dimorphic SC
compared to male spermatocytes. Regions of aggregated SYCP3 are seen from leptotene
through dictyate and are believed to be Nucleolus Organizer Regions (NORs). XLR3 signal is
consistently detected at these aggregate foci even at dictyate after the SC has served its
purpose (Figure 12). NORs were identified through co‐staining with anti‐Fibrillarin. The
implications of XLR3 localization to these aggregates is not known.
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Figure 12. Immunohistochemical Analysis of XLR3 in Meiotic Oocytes. XLR3 appears to localize
to aggregate areas of intensely staining SYCP3. The bottom panel displays XLR3 localization with
Fibrillarin, a marker for NORs.
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Chapter 3: Generation and Characterization of XLR3 Deficient Mice
Transmission Distorters
A transmission/segregation distorter is a genetic element that exhibits meiotic drive, the
ability of a genetic element to transmit inter‐generationally more frequently than the expected
Mendelian ratio of 50%. Genic meiotic drive relies on close linkage of elements increasing in
size through genetic hitchhiking of other genetic elements. Typically, transmission distorter
elements are referred to as "ultraselfish" DNA meaning that they offer no selective advantage
to the organism, but at the same time have no deleterious effects either.49 These genetic
elements are typically rich in chromosomal rearrangements as to decrease recombination
events for preservation of the region. These regions are referred to as "haplotypes" and have
the ability to cause large scale chromosomal meiotic drive events such is the case with
chromosome Ab10 in maize.50 In this case, a seemingly functionless repeat sequence on
chromosome 10 acts as a "knob" or heterochromatic region similar to a neocentromere. This
feature causes the chromosome to precociously move along the spindle poles and end up in the
upper or lower egg allowing for >50% chance of being inherited.51–53
Meiotic drive is seen in nature in many systems including spore‐killer (Sk) in fungi,
segregation distorter (Sd) in Drosophila melanogaster, and t‐haplotypes in mouse. The latter
case is the result of a variant form of chromosome 17 discovered ~70 years ago which
maintains a haplotype of inverted repeat sequences in tight linkage. This haplotype spans 20‐
40Mb and is observed in about 10‐20% of the Mus domesticus and Mus musculus lineages.50
Interestingly, a heterozygotic mouse carrying the t/+ alleles will preferentially pass on the
sperm with a "t" allele presumably due to induced disruption of the wild type (+) sperm carrier.
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This system requires the existence of a T complex responder (Tcr), a region within the t‐
haplotype that is required for preferential transmission and is found on both the t and +
allele.54–56 The Tcr in this case is a chimeric kinase protein capable of signaling flagellar
development which was discovered after finally being cloned in 2000 by John Schimenti and co‐
workers.57 This flagellar development protein causes defects for the trans (+) allele but has no
effect on the cis allele. The cis allele t‐haplotype contains T complex distorters (Tcd) which are
thought to work in causing the defect in trans.58 To date, 3 Tcd regions have been identified,
but how they cause sperm defects by manipulating the Tcr in trans is unclear.56
Drosophila melanogaster has perhaps the best studied segregation distorter mechanism
first discovered in 1956 by Sandler and Hiraizumi.59 In this system a responder (Rsp) element
exists on the second chromosome of some Drosophila alleles with a certain amount of copies of
a 240‐bp repeat sequence. Rsp sensitive (Rsps) alleles are composed of repeats arrays in the
range of 700‐2,500, while insensitive alleles (Rspi) have fewer repeats in the responder region
(100‐200). Alleles containing the segregation distorter (Sd) locus always carry the Rspi while the
other allele (Sd+) is subject to defects induced by the Sd allele. Sd codes for an enzymatically
wild‐type RanGAP protein, which for an unknown reason, mis‐localizes in the cell of drive
sensitive spermatids (Rsps). This effect occurs at Meiosis I and results in the death of Rsps
sperm, which are unable to transition chromosome conformation to the lysine/arginine‐rich
histone state.50,60 Many enhancers, modifiers and suppressors of the Sd allele have been
identified, indicating that regulation of segregation distortion is more complicated than initially
thought.
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Theory predicts that the effects of distorters will eventually be diminished by evolution
of unlinked suppressors restoring Mendelian ratios.28,61 In hemizygous systems such as
heterogametic sexes, sex chromosomes can evolve elements distorting their inheritance as well
as suppressors of distorters, ultimately leading to genetic arms races characteristic of
intragenomic conflict. This is best exemplified by Stellate, an X‐linked locus in flies, which has a
varying amount of repeats that directly distorts the inheritance of the Y chromosome. In low
copy number, Stellate, a protein homologous to the beta unit of casein kinase II, forms linear
crystals leading to a severe reduction in male fertility. In high copy number, Stellate, forms
"star‐like" crystal structures in spermatids resulting in completely sterile males due to non‐
disjunction in meiosis.62–64 Y‐chromosomes carrying the crystal (cry) or Suppressor of Stellate
[Su(Ste)] allele are able to suppress the distortion of Stellate, correcting the transmission of the
Y chromosome to 1:1. This suppressor effect in turn has led to an arms race where the X
chromosome is selected to accumulate more copies of Stellate while the Y‐chromosome
evolves more copies of Su(Ste) to suppress Stellate.

Intragenomic Conflict in Mice
In 2005 Burgoyne et al. published evidence for intragenomic conflict between X‐ and Y‐
linked genes based on mice with various size Y‐chromosome long arm (MSYq) deletions. These
deletions resulted in an up regulation of 23 transcripts, 15 of which emanate from the X and Y
chromosomes.65 Phenotypic changes in these mice included teratospermia becoming worse
with greater deletions and ultimately leading to infertility in some cases.24 In order to further
narrow‐down Y‐linked genes responsible for this effect, Cocquet and Burgoyne, generated a
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transgenic mouse ubiquitously expressing a short‐hairpin RNA targeting the abundantly
expressed multicopy Sycp3‐like Y‐linked (Sly) gene with hundreds of deleted copies in the Y
long‐arm deletion studies (Figure 13).4,48 Their scheme utilizes the strong RNA PolIII promoter
“U6” in order to drive high expression of the hairpin targeting transcripts from over 300 Sly
duplicates on the Y chromosome.66

Figure 13. Short Hairpin Targeting Scheme for Knockdown of Sly.

The ubiquitous expression of this short hairpin resulted in no off target effects and seemed to
only manifest a phenotype in testis. This phenotype matched very similarly to the Y
chromosome deletion studies having abnormal mature spermatid heads and significant gene up
regulation from the X and Y chromosomes. In fact, 86 genes on the X chromosome were
significantly up regulated along with 27 genes on the Y chromosome while only 1 gene showed
down regulation.28 Under wild‐type conditions these genes appear to be repressed by Sly
through recruitment of heterochromatic marks (H3K9me3, CBX1)4. The genes under Sly
repression include Gmd1l, Ssxb, Rhox, Speer, Slx, Slxl1, H2al1, and Cypt on the X and Ssty1/2,
Asty, Orly on the Y. The majority of these genes are found in multiple copies and have post‐
meiotic functions in testis.67
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Two of these repressed X‐linked multicopy genes, Sycp3‐like X‐linked (Slx) and Slx‐like 1
(Slxl1), show the same pattern of copy number amplification as Sly over the evolution of the
mouse sex chromosomes. Like Sly these genes also show predominantly cytoplasmic
localization in post‐meiotic spermatids.68 While conflict between Sly and its counterparts
Slx/Slxl1 is suggested by Sly’s transcriptional repression of these X‐linked genes, other evidence
suggests strong antagonism exists. Immunostaining of SLY and SLX/SLXL1 reveals competitive
localization to the sex chromosomes in round spermatids where they likely perform
antagonistic roles. Even more evidence for conflict was seen when litters from the Sly deficient
mice had litter sex ratios biased towards females while Slx/Slxl1 deficient mice had litters
biased toward males. This reveals a clear distortion effect for Slx/Slxl1 to increase the
inheritance of the X chromosome while Sly tries to silence this affect. Remarkably, mice having
deficiencies in both Sly and Slx/Slxl1 (presumably removing the distorter and repressor activity
completely), recovered a 1:1 sex ratio implicating these antagonistic genes in a pathway that
regulates the sex chromosome expression and inheritance. With cytoplasmic and nuclear
localizations of both these proteins it is unclear where exactly the conflict is occurring,
however, the downstream manifestations are very apparent.
Manifestation of transmission distorters are apparent just prior to allele inheritance.
Many of the phenotypic errors caused by distorters manifest during or after meiosis I resulting
in gamete dysfunction i.e; death of spores in (Sk) Neurospora caused by first meiotic division
segregation failure, improper flagellar development in t‐haplotype drive‐sensitive spermatids,
segregation distorter (Sd) in Drosophila causing RanGAP protein mislocalization in drive
sensitive spermatids, and Stellate in Drosophila which causes high levels of non‐disjunction and
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distorted sperm genotype ratios.50,63 Even the recently proposed Sly vs. Slx/Slxl1 conflict
appears to be occurring throughout spermiogenesis at the sex chromosomes in mice.4,5,48 XLR3,
sharing ~10% identity with SLX and SLY, also immunolocalizes to the sex chromosomes in round
spermatids, potentially implicating XLR3 in the same X and Y conflict. Xlr3 is a compelling
candidate to study in the context of sexual antagonism because one of three Xlr3 paralogs is
paternally imprinted, suggesting additional parent of origin regulation of this gene.8,69
Additionally, bioinformatic QTL analysis by Good, Dean, and Nachmann shows an 8.44Mb
region directly adjacent to the Xlr3 locus implicated in hybrid sterility, suggesting that loss‐of‐
function studies may reveal phenotypic abnormalities or sterility.68

Proof of Principle and Construction Scheme for Xlr3 Knockdown in vivo
In the present study, we created an Xlr3 deficient transgenic mouse in hopes to narrow
biological functionality of this multicopy gene as well as to observe evidence for a role in
distortion of the X and Y. As seen in chapter 2, XLR3 transiently accumulates during zygotene
and pachytene in meiosis I, immunolocalizing with SYCP3 exclusively at the XY body.
Consequently, a deficiency in XLR3 may phenotypically manifest as early as zygonema. Female
mice with XLR3 deficiencies may also manifest a phenotype based on XLR3 immunostaining in
oocytes. To engineer such a deficiency we chose a shRNA knockdown approaching targeting all
active copies of Xlr3. The short hairpin design shown below was manually generated based on
guidelines from Invivogen (http://www.invivogen.com/review‐sirna‐shrna‐design) for targeting
of the mature RNA from all of the Xlr3a,b,c,d and e, copies. In order to first test siRNA
biogenesis of the target sequence in cell culture, the sequence was cloned downstream of a U6
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promoter in an expression vector also containing a GFP selectable marker (U6‐Xlr3sh‐eGFP
plasmid seen in Appendix). An empty GFP vector was used as a control for the neonatal mouse
fibroblast transfections. Figure 14A displays the target hairpin which resulted in a ~50%
reduction in Xlr3 transcript in fibroblasts due to Xlr3 siRNA biogenesis (Figure 14B).

A.)

B.)

Relative Expression Xlr3

shXLR3 Transfection
2.5
2
1.5
Control
1

Knockdown
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0
Control

Knockdown

Figure 14. Xlr3 Short‐Hairpin Targeting Data. A.) Illustration of the Xlr3 siRNA in hairpin form.
B.) Quantitative RT‐PCR analysis of transcription levels of Xlr3 in control vs test RNAi
knockdown. Error bars represent confidence at 95% interval.

Full knockdown of the Xlr3 transcripts were not achieved likely due to incomplete transfection
of cells (efficiency ‐ 50%) ascertained through GFP fluorescence. FACs selection was not used
because the decrease in transcript is apparent without the separation of non‐transfected cells.
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Preliminary Characterization of Xlr3 Deficient Mice
With confirmation of the target sequence's ability to reduce Xlr3 transcripts, a
mammalian targeting vector was created to generate the knockdown system. The Rosa26 locus
on Mus chromosome 6 is commonly targeted for generation of high ubiquitous expression of
transgenes.70–72 Rosa26 is typically targeted with high efficiency in embryonic stem cells,
reaching up to 40% recombination efficiencies in many cases. Current evidence suggests XLR3
has a role confined to testis/ovary; however, to avoid the possibility of embryonic lethality or
infertile chimeric founders from loss of this protein, a conditional knock down strategy was
implemented. This is commonly achieved through insertion of a "floxed" STOP cassette in front
of the transgene (Figure 15), allowing for control of lox‐p site recombination in a tissue specific
manner. The Jackson Laboratories house many tissue specific Cre expressing strains including
the following pre‐meiotic expressing testis promoter strains: vasa/ddx4‐cre and str8‐cre
(http://jaxmice.jax.org/strain/006954.html).

Figure 15 – Illustration of the In‐vivo XLR3 shRNA Targeting Construct. The XLR3 siRNA
preceded by a floxed STOP cassette is contained within the 5’ and 3’ ROSA locus targeting arms
(not drawn to scale). Neomycin resistance for selection in mammalian cells is removable via
Flippase.
The steps already taken to generate this transgenic model are subsequently discussed;
however, breeding schemes are currently still on‐going to generate the knock down model. The
XLR3shRNA linearized construct was electroporated into C57BL/6J mESCs due to the fact that
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most of the information known about the Xlr locus comes from the C57 derived X‐chromosome.
The neomycin cassette provides G418 resistance for positive selection and diphtheria toxin A
(not shown) provides negative selection during mESC culturing. mESCs which survived selection
were screened for presence of a recombination event, expanded, and injected into a recipient
blastocyst by our collaborators at The Jackson Laboratory. With transgenic mESC giving rise to
black fur and recipient mESC giving rise to white fur, the resulting mice are referred to as
“chimeras” for having a mixed coat color. One would hope that the transgenic mESCs
contribute to the germline of these chimeric mice and therefore allow for generation of a fully
transgenic founder line when bred. The founder line is currently being bred, and initially, these
founders will be crossed with mice ubiquitously expressing flippase (FLP) recombinase for
prudent removal of the Neomycin selection cassette in all offspring. The resultant mice can
then be crossed with Cre‐recombinase expressing mice under a testis/time specific promoter.
Initially, reduced fertility will be scored via litter numbers and the sex ratios of those litters,
however, histology and SC integrity at the XY body will need to be examined via SYCP3
immunostaining. The breeding scheme is illustrated below in Figure 16.
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Figure 16 ‐ Illustration of Breeding Scheme for XLR3 Knockdown Mouse. In this scheme, the
linearized construct was electroporated into mESC for generation of chimeric mice were bred
for germ line transmission. Founders will be crossed to Flippase expressing mice and resulting
litters will be crossed to Testis‐Cre expressing mice for removal of the STOP cassette and
activation of the XLR3 shRNA (not drawn to scale).

40

Chapter 4: Epigenetics

Epigenetics and Genomic Imprinting
In 1942 C. H. Waddington proposed the term "epigenotype" to refer to the causal
mechanisms occurring in the void between genotypes and phenotypes.73 This definition
suggests a general mechanism which could and does have many components and complexities.
The term "epigenetics" was soon (1958) refined by David L. Nanney who claimed that aside
from genetic components owing to cellular outcome, "auxiliary mechanisms" control the
expression of the genetic material.74 Therefore, epigenetics describes heritable traits that are
independent of DNA sequence. Today's understanding of the term "epigenetics" is paramount
to understanding how genomes are poised for developmental processes and environmental
perturbations as was hinted so many years ago. Epigenetic mechanisms are known to manifest
in many ways, showing commonalities between species, and allowing insight into the
evolutionary necessity of these marks. Genomic imprinting and X chromosome inactivation
(XCI) are the two most studied epigenetic mechanisms in mammals, the molecular basis of
which is applied to the studies conducted in this thesis.
Genomic imprinting is characterized by mono‐allelic gene expression based on parent of
origin effects. Upon inheritance, maternal and paternal genomes retain specific "marks" or
modifications that don't change the nucleotide sequence but rather predispose it to activation
or silencing in the offspring. An evolutionary theory for this parental allelic predisposition,
termed "Parent‐Offspring Conflict" was realized in its earliest form by R.L. Trivers (1974), stating
that "...parent and offspring are expected to disagree over how long the period of parental
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investment should last, over the amount of parental investment that should be given, and over
the altruistic and egoistic tendencies of the offspring as these tendencies affect other
relatives."75 However, in addition to conflicting psychological tendencies toward offspring,
maternal and paternal contribution is also unequal at the epigenetic level as was shown by
Takagi and Cooper in the early 1970’s when revealing preferential inactivation of the paternal X
chromosome in extra embryonic tissues in mouse and kanagroo.76–78
In 1989, David Haig and Mark Westoby built upon Triver’s realization, proposing a
biological relevance for what they termed “parent‐specific gene expression” (PSGE) as it relates
to provisioning sibling resources. They state that one sibling can only be half related to the next
sibling of a different father, and therefore has an interest to benefit itself more than the next
sibling. This benefit manifests as the offspring re‐allocating maternal resources toward itself
during development. In this sense, the paternal genomic contribution should select for alleles
which exploit extra maternal resource, while this reallocation of maternal resources selects for
maternal alleles that avoid a drain of resources in hopes of future reproductive success.
Interestingly, Haig correctly predicts “…that there will exist a class of loci for which paternally
derived alleles are considerably more strongly expressed than maternally derived alleles. These
loci are predicted to encode proteins responsible for acquiring resources from the mother for
the offspring, and the PSGE in question should be found in the offspring tissue that acquires
resources.”79 In 1991, evidence for the first gene subject to PSGE was discovered, termed
Insulin‐like growth factor II (Igf2), an extremely potent mitogenic factor expressed during fetal
development.
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In their study, Dechiara et al, bred mice with a mutated form of Igf2 resulting in “growth
deficiencies” in progeny when passed through the paternal lineage. Passing the allele through
the maternal lineage revealed normal progeny and nuclease protection assays in the same
study would reveal paternal specific expression in embryos while the maternal alleles remained
silent.80 IGF2 was additionally shown to be imprinted in humans in a study exploiting a 3’ UTR
ApaI polymorphism to show paternal specific expression in human placentae.81 In mouse, Igf2
is located on distal mouse chromosome 7 in a 1Mb region of 12 imprinted genes, including the
non‐coding RNA H19 which is ~80Kb downstream from Igf2.82,83 Igf2/H19 are reciprocally
imprinted loci which fall under control of the same mechanism, relying on a differentially
methylated region (DMR) located 2Kb upstream of H19 identified by Tremblay and
Bartolomei.84 This region harbors at least 12 CpG dinucleotides that display hypermethylation
on the paternal allele coinciding with paternal specific repression of H19, and maternal allele
hypomethylation coinciding with maternal specific expression of H19.
The mechanistic link between Igf2 and H19 didn’t become apparent until 1995 when
Leighton and colleagues disrupted an enhancer 3’ of H19 affecting both H19 and Igf2
expression.85 Additional work done 3 years later by Thorvaldsen et al. deleted the differential
methylated region (DMR) 5’ of H19, resulting in loss of imprinted expression of H19 and Igf2,
thereby confirming the first imprinting control region (ICR).86 In 2000, Szabo and colleagues
identified 4 repeats of a 21 bp motif in the previously identified ICR and were able to show a
significant footprint of a zinc‐finger DNA binding protein on the mouse maternal allele which
was absent on the paternal allele.87 In the same month Bell et al. would show this zinc‐finger
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protein, termed CCCTC binding factor (CTCF), to bind DNA at the ICR in a methylation
dependent manner.88,89
Over the span of many decades the ideas of Waddington, Trivers, and Haig would be
realized, culminating in the mechanism seen in Figure 17 below. On the maternal mouse
chromosome 7, an imprinting control region (ICR) ~2kb upstream of the H19 transcriptional
start site is hypomethylated allowing for the insulator protein CTCF to bind. This results in the
preferential association of downstream enhancers with the H19 promoter, activating it. Lack of
enhancer activity at the maternal Igf2 promoter results in silencing. On the paternal allele, the
ICR is preferentially hypermethylated abolishing CTCF occupancy at this region and inducing a
long‐range chromatin interaction (~80kb) of the 3’ enhancers with the Igf2 promoter, activating
it. Paternal H19 is silenced due to lack of enhancer activity at the hypermethylated promoter. It
should be noted that in addition to the differential methylation seen at the ICR upstream of
H19, there exists 2 other DMR’s, “IGF2 DMR0” and “IGF2 DMR2”, which are located in intron 2
and the 3’ UTR of Igf2, respectively. These regions are normally paternally methylated and are
not considered part of the ICR; however, studies involving growth impairment reveal
hypomethylation of these alternate DMRs coinciding with abnormal Igf2 gene expression.90
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Figure 17. Mechanistic View of the Imprinted Igf2/H19 Locus in Mouse. This locus is regulated
by a differentially methylated region upstream of H19.91

Paternal allelic expression of Igf2 aims to increase nutrient exploitation for growth at
the provider’s expense, and is therefore repressed by the maternal lineage. Also implicated in
this conflict and antagonistic to Igf2 is the cation‐independent mannose‐6‐phosphate receptor,
Igf2r, which acts as a receptor for Igf2 in mouse and humans. Interestingly, Igf2r is also
imprinted displaying maternal‐specific expression after embryo implantation.92 Mutations in
this receptor results in embryonic over‐growth as well as increased extra cellular levels of Igf2
suggesting it controls the growth signaling of Igf2.93–95 With the maternal allele active, Ifg2r acts
in regulating high expression of paternal Igf2, while the paternal lineage predisposes this
receptor to be inactive with the purpose of preventing Igf2 regulation. In this sense, maternal
and paternal alleles must contribute unequally to the progeny in order to keep a balance in
growth factors/receptors for creation of viable offspring. One would hypothesize, if the
parental genomes contribute equally, then two paternal or two maternal genomes could be
combined in a parthenogenetic manner for successful generation of an offspring. In fact this is
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not the case with mammals as was demonstrated by zygotic nuclear transplantation
experiments from which Surani and Barton concluded that the genomes must be marked such
that different maternal and paternal contributions are necessary for viable offspring.96–98
To date, there have been ~160 imprinted genes identified between mouse and human,
the vast majority of which fall into clusters on autosomes (www.mousebook.org). Many of the
well‐studied imprinted loci share other commonalities such as the presence of reciprocally
imprinted long non‐coding RNAs, which are currently being intensely studied in the field (i.e.
Kcnq1ot1, Air, and Xist/Tsix).99 But, above all else, the hallmark of epigenetic regulation at these
loci involves the presence of differentially methylated regions. As discussed earlier, the DMR
upstream of H19 controls imprinting of the cluster, however, control of imprinted expression
on the same chromosome at Kcnq1 is determined by a separate DMR/ICR. This DMR regulates
silencing of a cryptic promoter for a long non‐coding RNA (Kcnq1ot1) on the maternal allele but
results in activation of Kcnq1 on the paternal allele.100 It should be noted that imprinted
clusters are much more complicated than originally thought, as is the case with Dlk/Gtl2, which
has 3 DMRs, two of which control imprints in different ways when deleted and result in many
differences in activating and repressive histone modifications.101 On top of this, Dlk/Gtl2
harbors many snoRNAs which are thought to act through RNAi biogenesis to regulate Dlk in
trans.99

X‐chromosome Inactivation
A crucial epigenetic mechanism exists in eutherian mammals during X‐chromosome
inactivation (XCI), the random transcriptional repression of one X chromosome in all female
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cells. Muller saw such a mechanism as necessitated by the unequal inheritance of the sex
chromosomes between the homo/heterogametic sexes in order to effect dosage
compensation, manifest as silencing one X in females to match the hemizygous nature of the
male X.102,103 Additionally, according to Susumu Ohno (1967), in order to meet expression of the
duplicate autosomes, the remaining active X must compensate by doubling expression of its
2,000+ genes.104,105 Recently, Ohno's hypothesis has been challenged by new studies utilizing
RNA‐seq and microarray technologies to cast doubt on the hypothesized 1:1 X:AA expression
ratio.105–109
Visually, the inactivated X chromosome was discovered by Barr and Bertram who
observed dense chromocenters exclusively in female neurons indicative of an inactive X
chromosome, later termed "Barr Body."110 Mary Lyon also showed evidence for this mechanism
in 1961 when observing the variegated coat colors in female mice due to their X chromosome
mosaicism.111 The genes subject to silencing during XCI remain so in future cell lineages, a clear
example of epigenetic inheritance. XCI is controlled by the X‐inactivation center (Xic) where the
gene X‐inactive specific transcript (Xist) is located and transcribes a long non‐coding RNA (15kb)
which "coats" the X chromosome destined for inactivation.112,113 Ultimately, Xist is thought to
be regulated by a multitude of other non‐coding RNAs in the region (Xite, RepA, Jpx, and Tsix),
and its spread along the X undergoing inactivation may occur by one of two proposed models.
With evidence of only one control center (Xic) it could be that each gene region has its own
recruiting capabilities for silencing; however, more popular is the idea that Xist loads at the Xic
and is able to propagate outward through YY1 tethering to “spaced booster elements” to aid in
global silencing.114
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The stable repression of the inactivated X is ensured through epigenetic means such as
the heterochromatic marks, H3K9 dimethylation, H4K20me, H2AK119ub1, H3K27me3, and
incorporation of the histone variant macroH2A.1, while active marks are removed via H3K9
hypoacetylation and H3K4 hypomethylation.115–118 Conversely, the X chromosome destined to
remain active transcribes Tsix, which is an antisense transcript to Xist, that prevents initiation of
silencing on the future active X.119,120 Again, it should be noted that an imprinted form of X‐
inactivation occurs early in development (2‐cell stage) of metatherian and eutherians in which
the paternal X chromosome is exclusively inactivated. The paternal X remains inactive in all
tissues in metatherians, however in eutherian blastocyst stage embryos all cells in the Inner Cell
Mass (ICM) reactivate to prepare for random XCI, while cells associated with the
trophectoderm keep their paternal X inactive.76,121 XCI is therefore perhaps the most dynamic
and large scale epigenetic mechanism known, involving differences in all major players; DNA
methylation, non‐coding RNA, variable histone marks, and conformation factors. It should be
noted that Xist has not been located in marsupials but rather an analogous long non‐coding
RNA termed Rsx seems to play a role in inactivation of the paternal X.122

Roles for CTCF and YY1 in Epigenetic Gene Regulation
Gene expression follows a general mechanism of transcription factor binding to a
regulatory sequence (RNA Pol II and TFII family members) followed by nearly simultaneous
recruitment of activating or repressive nucleosome remodeling complexes and histone
modifying enzymes. In addition to this orchestration of positive and negative factors,
eukaryotes have evolved machinery connecting distant enhancers and promoters to achieve
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proper transcription in many cases. The hallmark protein of such interactions, CCCTC‐binding
factor (CTCF), is an 11 zinc‐finger DNA binding protein first discovered for its repressive
regulation of the c‐myc oncogene by binding a consensus sequence in the promoter
region.123,124 CTCF is highly conserved from fruit flies to humans and the central zinc finger
domain retains 100% identity between birds and humans.125 Interestingly, CTCF has a very
loose consensus binding sequence attributed to the fact that it uses different combinations of
the 11 zinc fingers to bind a variety of regions.126 In mammals CTCF has ~55,000‐65,000 binding
sites of which ~5,000 are extremely conserved between different species and tissues.127 About
50% of total mammalian sites appear to be used in tissue specific instances making it important
in laying the unique topography of many cell lineages. Additionally, 50% of total mammalian
CTCF sites fall near promoters and within gene bodies bolstering a role in gene expression
mechanisms.128–131
While it was initially discovered as a repressive transcription factor, CTCF was soon also
appropriately defined as an “insulator” for its roles in suppressing the spreading of
heterochromatin. CTCF’s function is best exemplified by circular chromosome conformation
capture (4C) experiments suggesting extensive inter‐ and intra‐chromosomal interactions at the
H19 DMR, dependent on CTCF occupancy, which is ultimately dependent on DNA
methylation.132 Additional work showed that enhancers downstream of H19 interact with its
promoter in the presence of CTCF, but form a larger chromatin loop to the Igf2 promoter in the
absence of CTCF at the ICR.89,133–135 CTCF therefore lays down a topography for which DNA
looping is determined. This topography is exemplified at the mouse homeobox A cluster (Hoxa),
where two chromatin loops form around a CTCF binding site which ultimately splits the cluster
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into two distinct domains. The Hoxa1‐7 loop is enriched for the activating histone modification
H3K4me3, while the Hox9‐13 loop is enriched for the repressive mark H3K27me3. This allows
for specific Hox gene expression in a tissue and time specific manner. Knockdown of CTCF in
this system reveals a spread of H3K27me3 across the entire locus resulting in silencing of all
Hox genes in the cluster.136
In a study targeting the long range interaction landscape of gene promoters through 5C,
Dekker and colleagues found that only 7% of chromatin interactions were with directly proximal
genes and, contrary to repressive activity, CTCF is significantly enriched at distal interactions
along with many active enhancer histone modifications. In the same study 79% of distal
interactions showed a lack of CTCF blockage and rather an enrichment of enhancer activating
marks further supporting its ability to tether distant enhancers to their promoters in a positive
manner.137
The “looping” which is governed by CTCF can be extremely complicated as seen in the
example below (Figure 18).
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Figure 18. Mechanistic View of the Protocadherin (PCDH) Genes. Generation of varying 5’ exons
is accomplished through looping coordinated by Cohesin, CTCF, and enhancers – Figure
courtesy of Ong and Corces.131

In this model, the protocadherin (PCDH) genes, which are responsible for neuronal
diversity, have a very complex mechanism for promoter and alternatively spliced exon
choice.131 The many different forms of PCDH have incorporation of variable 5’ exons followed
by a common domain seen in all isoforms. The HS5‐1 enhancer seen above, is tethered to
certain promoters via cohesion and CTCF. Each of the first 13 exons has its own promoter and
in this example exons 4, 8, and 12 are poised for expression and incorporation into a variable
form of PCDH.138–140
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These mechanisms utilize other transcription factors including PR domain zinc‐finger
protein 5 (PRDM5), zinc‐finger protein 143 (ZNF‐143), chromodomain helicase DNA‐binding
protein 8 (CHD8), PARP1, MYC‐associated zinc‐finger protein (MAZ), JUND, nucleophosmin and
perhaps most importantly – Cohesin.141 50‐80% of CTCF binding motifs are occupied by cohesin
whose SA2 subunit has been shown to interact with the C‐terminal domain of CTCF.135,142
Cohesin is ultimately responsible for the physical structuring of DNA around CTCF sites and is
indispensable for proper Igf2/H19 looping and imprinted expression.135 More recent studies
involving CTCF and cohesin utilized a technique termed “Hi‐C” which captures all interacting
chromatin regions through protein crosslinks and sequences this pool for a global view of the
genomes’ “interactome.” Interestingly, only 15% of CTCF binding sites fell in the border regions
of Topologically Associated Domains or TADs while the other 85% of CTCF sites fell inside the
TADs. TADs are defined by regions of genes that show a large amount of interaction with each
other and not with other TADs. With the majority of CTCF falling within these regions it seems
likely that CTCF’s major role isn’t to form TAD borders but is instead to form intra‐TAD
interactions.143–146 This role is exemplified through the many examples listed earlier.
Another major player in these tethering mechanisms is Yin Yang 1 (YY1), a 4 zinc‐finger
protein known to interact with TBP, p300, c‐myc, and HDAC2. Additionally, YY1 harbors a
“REPO” domain, which recruits polycomb group proteins (PcG) resulting in trimethylation of
H3K27. YY1 was initially discovered when Kassis et al. cloned the Drosophila Pleiohomeotic
(PHO) gene sequence, and noticed 2 domains with homology to mammalian YY1. PHO itself is
PcG protein and is thought to anchor PcG proteins to DNA, a function consistent to YY1, which
behaves like a PcG protein in vivo.147,148 YY1, like CTCF, functions very broadly in the regulation
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of gene expression, having been implicated in X‐chromosome inactivation, imprinting,
oncogenesis, viral gene expression, and embryonic development.149,150
CTCF and YY1 work together in one of the best‐studied looping mechanisms involving
the B‐cell immunoglobulin (Ig) and T‐cell receptor (Tcr) loci which must be conformationally
poised correctly in order for proper immunoglobulin formation. These loci are characterized by
a variable region (V), a diversity region (D), and a joining region (J), which can create an
enormously large diversity of receptors during lymphocyte maturation and development.
These loci span very large regions (~3Mb) and become rearranged through use of two
recombinases, termed Recombinase‐Activating Gene 1 and 2 (RAG1/RAG2).131,151,152 In Figure
19, the immunoglobulin heavy chain complex (Igh) locus uses a combination of enhancer
sequences, RAG sequences, CTCF and YY1 sites for correct recombination between the many
gene segments.
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Figure 19. Mechanistic View of the B‐cell Immunoglobulin and T‐cell Receptor (Tcr) Locus. A.)
Gene segment representation of the VH, DH, JH, and CH regions. B.) Illustration of the
complicated looping mechanisms involving CTCF, YY1, and enhancers that direct reorganization
of the Igh locus. Figure courtesy of Ong and Corces.131

Issues with the formation of these critical loops can result in immunodeficiencies and
often lead to lymphoid malignancies.153 This thesis aims to look at CTCF involvement in
regulation of an imprinted locus, but it should be mentioned that CTCF, cohesin, and YY1 also
play roles in mitosis during replication as well as chromosomal condensation making them
critical in setting up landscapes throughout the entirety of the cell cycle.
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Methylation and ICRs
Cytosine residues adjacent to a guanosine residue (CpG) can be actively targeted by
DNA methyltransferase proteins in order to create a modified nucleoside termed 5‐
methylcytosine. These marks are commonly found in regions of high CpG content known as
CpG islands where the CG residues exist in an observed‐to‐expected ratio greater than 60%.154
This is generally known to be a chromatin silencing mark resulting in tighter chromatin
compaction. 70‐80% of total CpGs in mammals are methylated, while, conversely, 70% of CpGs
found at promoters remain hypomethylated, presumably to allow transcription to occur.155,156
De‐novo methylation, such as allele specific methylation that occurs in imprinting, is set up by
the DNA methyltransferases, Dnmt3a, Dnmt3b and Dnmt3l.157 De‐novo methylation at
imprinted loci is set up in the germ line and remains in place throughout global zygotic
demethylation of the paternal genome, followed later by the maternal genome.158 Deleting
Dnmt3b and Dnmt3l results in embryonic lethality, while deletion of Dnmt3a leads to post‐natal
lethality, further exemplifying the necessity of these proteins to set up important de‐novo
epigenetic marks for developing embryos. A fourth DNA methyltransferase, Dnmt1, is known to
maintain DNA methylation marks throughout the cell cycle, having the ability only to fully
methylate hemi‐methylated DNA.159–161
Numerous methyl‐binding domain proteins work in further recruitment of DNA
modifying and chromatin effector proteins. One such methyl‐binding protein, Methyl CpG
Binding Protein 2 (MeCP2), localizes to CpG methylation globally. In general, MeCP2 binds to
methylated DNA to block or enhance DNA binding of activators or repressors. MeCP2 is located
on the X chromosome in mouse and humans, and its various mutated forms underlie
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neuropathological disorders, including Rett Syndrome (RTT).162 RTT manifests in early
development in humans (6‐18 months) where phenotypes such as microcephaly, general
growth retardation, ataxia and seizures are seen.163 More recently, studies in mice show MeCP2
to be necessary for recruitment of alpha thalassemia/mental retardation syndrome X‐linked
(Atrx) chromatin remodeler encoded by a gene that when mutated causes Alpha Thalassemia X‐
linked Intellectual Disability Syndrome (ATR‐X), a severe intellectual disability disorder.164 ATRX
contains a SWI/SNF domain allowing it to remodel chromatin in heterochromatic regions and
appears to be enriched at GC‐rich regions of the genome, repeat sequences and telomeres. In
fact, MeCP2 targets ATRX to DNA secondary structural regions known as ‘G‐quadruplexes’ (G4s)
which are defined by 4 consecutive duplicates or triplets of guanosines that interact through
Hoogsteen pairing.164,165 This type of pairing occurs between guanosines when the DNA is
opened up at the replication fork, or during transcription, causing a replication fork or
transcriptional stall.166 This affect has been shown to occur in an allele‐specific manner at 8.5%
of the genome including imprinted genes and regions of large deletions. ATRX is targeted to
these regions, especially at telomeres to counter G4 formation to ensure telomere structural
stability. In fact, deficiencies in ATRX induce telomere dysfunction, potentially through
abnormal lengthening of telomeres.167,168 ATRX is thought to cull such affects through
recruitment of H3.3, a histone variant associated with open chromatin and active
transcription.169 Interestingly and significant to this thesis, ATRX was recently found to be
recruited to the promoter of the mouse X‐linked imprinted gene Rhox5, contributing to
regulation of its expression.170 Additionally, MeCP2/ATRX binds the maternal allele ICR of
imprinted H19, loss of which prevents post‐natal repression of this non‐coding RNA.171 In fact,
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loss of ATRX was also shown to derepress many imprinted genes post‐natally, including
Gtl2/Dlk1. In their study, Kernohan et al, revealed allele‐specific binding of MeCP2/ATRX at ICRs
for many imprinted loci, loss of which caused a change in nucleosome occupancy at CTCF
consensus binding sites common to ICRs resulting in abolishment of long‐range chromatin
interactions coincident with changes in gene expression.164
While MeCP2 seems to function broadly by binding methylated CpGs globally, another
zinc‐finger DNA binding protein, ZFP57, is shown to bind and protect maternal methylation
exclusively at ICRs and its 6 base pair consensus sequence (TGCCGC) is found at all known ICRs
except one. ZFP57 is thought to set up methylation memory at ICRs specifically on the maternal
allele, and loss of ZFP57 results in embryonic lethality.172,173

Epigenetics in Cancer and Disease
Global DNA hypomethylation is a key characteristic of tumorigenesis with the exception
of certain sites with specific CpG hypermethylation.174 The hypomethylation of many different
genetic elements, including repetitive sequences and retrotransposons, leads to DNA instability
which can take the form of increased expression of growth factor genes such as T‐Tas, MAPSIN,
MAGE (melanoma‐associated antigen), and even IGF2.175,176 In a seminal study by Ehrlich in
2003, a patient with immunodeficiency, centromeric region instability and facial anomalies
syndrome (ICF) was revealed to carry a mutant form of DNMT3B, which resulted in global
hypomethylation, linking hypomethylation to instability.177,178 Loci that are selectively
hypermethylated tend to fall under the category of “tumor suppressor genes” (p16, MLH1, and
BRCA1).179 As discussed earlier, BRCA1 and MLH1 are crucial factors involved in the DNA repair
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pathway in somatic and germ cells, and are therefore essential to proper cell development.
How these genes are targeted for hypermethylation isn’t well understood currently.
Aberrant DNA methylation is only partially explanatory in tumorigenesis. For a multitude
of cancers, high expression of histone deacetylation proteins (HDACs) is consistent with loss of
the activating histone modifications, H4K16ac/H4K20me3, resulting in repression of tumor
suppressor genes.180,181 Additionally, the histone methyltransferase, EZH2, is over‐expressed in
prostate and breast cancers, and is responsible for altering the methylation of H3K27 and H3K9
at aberrantly expressing genes.182 EZH2 is also responsible for the reversible silencing of key
developmental genes by trimethylating H3K27. In cancer cells, this trimethylation mark was
recently shown to be a precursor for de novo DNA methylation, potentially explaining at least a
portion of aberrant methylation.183 It should be noted that miRNAs, which are involved in
transcription factor regulation, cell proliferation and apoptosis, also become deregulated in
cancer, acting as both oncogenes and tumor suppressors. Another facet of chromatin
architecture relatively unexplored in cancer is nucleosome occupancy, connecting fine‐scale
physical gene structure to tumor formation.178
With such power over gene expression, it is no surprise that epigenetic mis‐regulation
can result in disease. As mentioned earlier, parentally established allelic marks from both
parents are essential for viable development of mammalian offspring. Angelmann Syndrome
(AS) is caused by inheritance of both chromosome 15s from the paternal lineage or maternal
deletion of a key region on chr15.184 Phenotypic manifestations include more frequent laughter
and smiling, abrupt limb movements, and general mental retardation. The locus responsible
resides at 15q11‐13 which harbors multiple imprinted genes with paternal specific expression
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(Snurf/Snrpn, Znf127, Nectin, Mkrn3, and Magel2).185–187 Conversely, when the progeny inherits
both chromosome 15s from the maternal lineage, or a paternal chr15 regional deletion, a
similar disorder known as Prader‐Willi Syndrome (PWS) results. PWS is characterized by
hypotonia and hypogonadism early on and docile behavior coupled with excessive eating after
infancy. These phenotypes are consistent with the idea that disruptions to imprinted genes
generally lead to growth abnormalities making them good candidates for gene therapy.
Improper genomic imprinting has also been hypothesized to contribute to Autism
Spectrum Disorder (ASD). ASD is a complex developmental disability manifest as impairments in
communication, learning, and forming relationships. Interestingly, 14.7 per 1,000 8‐year old
children were shown to have some form of ASD, with a sex bias affecting males much more
commonly than females (4.3 to 1).188 Fetal testosterone is being intensely looked at to explain
this bias, however, to date, no male‐specific factor has been identified to explain its prevalence,
and instead a new hypothesis has begun to emerge termed the “Female Protective Effect”
(FPE). FPE states that unknown female‐specific factors are able to somehow prevent reaching
the threshold of ASD in a background of non‐sex‐specific predisposing influences.189 As
mentioned previously, fetal testosterone has been suggested many times as being the male‐
specific vulnerability factor, potentially causing an “extreme male brain effect” which manifests
as ASD, but evidence for this theory has so far been lacking.190
Equally as relevant is the idea that the significant sex bias in autism could be due to an
imprinted locus on the X chromosome, which will be phenotypically much more prominent in
males who are hemizygous for the X‐chromosome. This idea emerged from a study conducted
by Dr. David Skuse, a British psychiatrist studying social cognitive defects in Turner Syndrome
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patients. Turner syndrome is characterized by X chromosome monosomy in females resulting
in phenotypes similar to ASD; i.e. ‐ behavioral deficiencies such as hyperactivity, learning
impairments, and poor social interactions.191,192

Figure 20. Turner Syndrome Cognitive Study. Relative scores from cognitive tests conducted by
Dr. David Skuse on X monosomic (Turner Syndrome) females. Higher scores coincide with
poorer cognitive ability. Figure courtesy of Skuse et al.191

In his study Dr. Skuse subjected 45,Xm and 45,Xp female patients to social cognitive tests and
revealed a significant difference in performance based on the parental origin of the X
chromosome (Figure 20). Xm carrying females scored higher and therefore worse compared to
Xp carrying females. He later hypothesized that this could be due to an X‐linked imprinted gene
locus or loci. As discussed earlier, in 2005 Raefski and O’Neill discovered the first X‐linked
imprinted genes in mouse, X‐linked Lymphocyte Regulated (Xlr) 3b/4b/4c, work that was
inspired by the observations of Skuse and colleagues.8

The Xlr3b, Xlr4b, Xlr4c Imprinted Locus
Like many autosomally imprinted genes, Xlr3b, Xlr4b and Xlr4c are present in a cluster
displaying maternal specific expression (Figure 21A and B). Raefski and O’Neill utilized X
monosomic female mice with either the maternal X (39, Xm) or the paternal X (39, Xp) to show
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significant allelic expression differences in Xlr3b/4b/4c. Reciprocal crosses of two inbred mouse
strains, C57/C3H, provided proof of the imprint in normal females, thereby providing the first
candidate genetic locus for Skuse’s theory.

A

B

Figure 21. Discovery of an Imprinted Cluster of Genes at the Xlr Locus. A.) Allele/Paralog‐
specific imprinting assay on 39,Xm and 39,Xp neonatal mouse fibroblast. B.) Illustration of the
X‐linked Lymphocyte Regulated (Xlr) locus at XA7.2 (mm10) ‐ imprinted paralogs are seen in
blue. Figures courtesy of Raefski and O’Neill.8

This locus (XA7.2) harbors members of the Xlr superfamily of genes, which exist in hundreds of
copies on the murine X and Y chromosomes. As discussed in Chapter 1, the primary function of
this gene family appears to be involvement in repression of gene expression from the X and Y
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chromosomes during spermatogenesis. Although relatively high expression of Xlr3/4/5
transcripts in brain, fibroblast, and lymphocytes suggested other functions, the XLR3 protein
has only been detected in testis and oocytes. Interestingly, an antibody raised against the Xlr4
N‐terminus reveals a band of the correct size on a western predominantly in the cytoplasm of
neonatal whole brain and fibroblast (Figure 22). This is counter to the expression status of all
other XLR superfamily proteins but is consistent with the high mRNA expression of Xlr4 in brain
and fibroblast.

Figure 22. Western Blot probed with anti‐XLR4. Cytoplasmic and nuclear fractioned tissue was
probed with a custom anti‐XLR4 antibody revealing a prominent band in mouse brain and
fibroblast.

Two other imprinted genes have been found on the mouse X‐chromosome; ferritin, heavy
polypeptide‐like 17 (Fthl17), a maternally silent gene which becomes paternally expressed
starting at the 2‐cell stage of embryogenesis, and Rhox5/Pem, also a maternally silent gene
which is paternally expressed up until the morula stage when the imprint flips and maternal
expression predominates.193–195 Both genes have high expression in testis/oocytes and appear
to have roles in gonad development.
Investigation of the imprinting mechanism involved in paternal silencing of Xlr3b/4b/4c
was initially carried out by Dr. Michael Murphy, Dr. Sohaib Qureshi, Dr. Seth Kasowitz, and Dr.
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Ben Carone. Since parental‐allelic differences in DNA methylation are the global epigenetic
mark of all well‐studied imprinted loci, the interrogation of the Xlr3b/4b/4c imprinting
mechanism began with a search for differential methylation of CpG residues. CpG islands were
bioinformatically identified at XA7.2 and subject to sodium bisulfite treatment followed by
Sanger sequencing. Figure 23 below shows the methylation status of CpG dinucleotides at each
island across the locus. Surprisingly, both parental copies are hypermethylated for each of
these loci, despite active transcription of only the maternal copies. No significant allelic
differential methylation is seen except at F8a in the normal XX genotype. F8a was included as a
control since it resides in the middle of the imprinted Xlr cluster, but is not itself imprinted. F8a
shows the expected 50% methylation attributable to XCI in normal females, but
hypomethylation in monosomic females.

Figure 23. Sodium Bisulfite Sequencing of CpG Islands at XA7.2. Blocks of clones represent
various CpG islands across the Xlr locus. Methylated CpGs are indicated by filled in “lollipops”
while unmethylated CpGs are blank. Results courtesy of Dr. Seth Kasowitz and Dr. Ben Carone

Methylated Binding Domain protein immunoprecipitation hybridized to tiling array (MeDIP‐
chip) experiments performed by Dr. Michael Murphy did not reveal a DMR within 2 Megabases
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spanning the Xlr locus (data not shown). While investigating the processing and disposition of
the Xlr3b mRNA in the cell nucleus, Dr. Seth Kasowitz discovered that while the processed
transcript showed maternal dominant expression, the 5’ end of the primary transcript was
biallelically transcribed (Figure 24). Maternal dominant expression isn’t detected in the primary
transcript until at least intron 7.

Figure 24. Quantitative RT‐PCR Analysis of Xlr3b Primary Transcript. qRTPCR of the Xlr3b
primary transcript assayed at various positions across the gene revealing lack of a transcript on
Xp neonatal brain at Intron 7. Figure courtesy of Dr. Seth Kasowitz.

These findings suggested that the imprinted expression of Xlr3b may be manifest at transcript
elongation or processing. To investigate this possibility, Dr. Sohaib Qureshi performed
Chromatin Immunoprecipitation (ChIP) to characterize the chromatin architecture and the
profile of RNA Polymerase II occupancy on the two parental alleles of Xlr3b. Equal expression of
the 5’ end of the paternal transcript suggested that transcription may be initiating but failing to
complete elongation or processing on the paternal allele. Figure 25A below shows enrichment
of total RNA Polymerase II across the Xlr3b gene in X‐monosomic tissues. There appears to be
an increase of RNA Pol II on the paternal allele at the Intron 3/Exon 4 boundary while more
maternal RNA PolII successfully makes it to the end of the gene. This data is corroborated by
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results from an immunoprecipitation using an antibody specific to “elongating” RNA Pol II,
which shows a clear increase in actively transcribing Pol II at Intron 3/Exon 4 while, again, more
maternal RNA PolII makes it to the end of the gene (Figure 25B). This data suggests an RNA Pol
II stall on the paternal allele of Xlr3b due to an unknown mechanism.

Figure 25. RNA Polymerase II Enrichment across Xlr3b. A.) Quantitative RT‐PCR of RNA PolII
(4h8) ChIP enrichment across Xlr3b. B.) Quantitative RT‐PCR of RNA PolII (Ser2) ChIP
enrichment at Xlr3b. Both histograms indicate a buildup of RNA PolII in the middle of the gene
at intron3/exon4. Figure courtesy of Dr. Sohaib Qureshi.
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Figure 26. Real‐Time PCR of H3K36me3 ChIP Enrichment at Xlr3b. Graph shows the paternal
allele is 3 to 4 fold more enriched for H3K36me3 than the maternal allele at intron3/exon4
(Int3/Ex4). Enrichment at all regions is relative to total histone H3 ChIP and normalized to the
Gapdh TSS. Figure courtesy of Sohaib Qureshi.

The only other chromatin difference observed between the maternal and paternal alleles of
Xlr3b is an increase of H3K36me3 on the paternal allele at the Intron3/Exon 4 boundary (Figure
26) while H3K4me3, H3k9me2, and H3K27me3 remained equally enriched at all regions (data
not shown). This mark could be a result of an increase of stalled RNA PolII on the paternal
allele, which in turn increases the recruitment of SETD2, the H3K36 trimethylase enzyme that
works co‐transcriptionally with RNA PolII. While these results show how the imprint is
manifesting during transcription it doesn’t make clear the cause of the RNA Pol II stall. The next
chapter shows that a closer look into the proximal gene, Factor 8 associated gene (F8a), reveals
regulatory elements consistent with other imprinted loci and leads to a model of Xlr3/4
imprinting.
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Chapter 5: Allele Specific Differences at the Imprinted Xlr3/4/5 Locus

Factor 8 associated gene A (F8a)
Internal to the imprinted Xlr paralogs exists a biallelically expressed gene, Factor 8
associated gene A (F8a) (Figure 27). This gene has one exon (~2.5Kb) and in humans it is located
inside intron 22 of coagulation Factor 8 (F8). While F8 is involved in blood clotting, F8a has been
shown to code for a 40kDa protein termed HAP40, or Huntingtin‐associated protein 40, which
co‐purifies with the protein product involved in Huntington’s disease termed Huntingtin
(HTT).196 It is suggested that F8a is necessary for proper function of HTT. As seen below F8a is
single copy in the mouse genome but has 3 copies (F8a1, F8a2, F8a3) in the human genome,
one residing in intron 22 of F8 (Figure 28).

Figure 27. Cytogenetic Location of F8a in Mouse. Genomic representation of single copy F8a
and adjacent imprinted genes.
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Figure 28. Cytogenetic Location of F8a in Human. F8a is multi‐copy in humans (F8a1, F8a2, and
F8a3) all found near the telomere.
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Interest in relating F8a to the Xlr3b/4b/4c imprinting mechanism came when ENCODE
released ChIP‐seq tracks of transcription factor binding locations revealing prominent
enrichment of the insulating protein CTCF in the gene body of F8a in several tissues and cell
lines from mouse. As discussed earlier, CTCF has been implicated in the regulation of gene
expression and in particular imprinted expression at the Igf2/H19 locus. CTCF directs chromatin
loop formation to promote enhancer/promoter interactions and acts in insulating key regions.
Interestingly, p300, a mark for active enhancers, is seen flanking the main CTCF peak in F8a, as
shown in Figure 29 below.

Figure 29. Pile‐up of CTCF and p300 Tracks from ENCODE. CTCF insulator and p300 enhancer
marks at F8a ‐ figure adapted from ENCODE.

Internal to F8a, where the CTCF peak resides is a large CpG island which extends for the first
half of the F8a coding region. Figure 30 below illustrates the location of this CpG island within
F8a and displays the location of consensus binding sequences for CTCF, YY1, and ZFP57.
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Figure 30. Illustration of Consensus Sequence Locations in F8a. Indicators of potential
regulation and looping exist at the 5’ end of F8a.

The numerous indicators of looping interactions sitting in the middle of the imprinted
Xlr paralogs, compelled a series of experiments to determine if these chromatin features may
be involved in the imprinted expression of the neighboring paralogs. Since DNA methylation is
the differentiating hallmark of ICR’s, this was the first epigenetic mark to be investigated in F8a.
In order to do so, mouse models were used to produce X‐monosomic mice with either the
maternal or paternal X chromosome (Figure 31). In this breeding scheme, germ cells carrying
the In(x) or Paf alleles will undergo non‐disjunction during meiosis resulting in the passing of a
single wildtype C57 X chromosome.
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Figure 31. Breeding Schemes for the Generation of X‐monosomic Mice. Courtesy of Dr. Michael
O’Neill.

These mice are viable and only show slight behavioral differences when compared to wild‐type
C57 mice.197 Previous work in this mouse model by Raefski and O’Neill show Xlr3b/4b/4c to be
imprinted in neonatal whole brain and neonatal fibroblast making them good target tissues for
identification of a DMR.8

Differential Methylation at F8a
In a simple assay to test for a DMR, Xm and Xp neonatal whole brain DNA was digested
with a methylation sensitive restriction enzyme (HpaII) and subject to PCR amplification.
Existence of a PCR band suggests a methylation block of HpaII cutting while absence of a band
represents complete cutting and therefore complete hypomethylation. In Figure 32 below, a
clear difference can be seen at F8a, which has no methylation in Xp but at least some
methylation in Xm.
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Figure 32. HpaII Methylation Assay at F8a. “F” and “R” mark the primers used to amplify the
region containing 3 HpaII sites in neonatal whole brain. Successful cutting of one of these sites
would be indicative of no band and therefore hypomethylation. Conversely, a positive band
would indicate incomplete cutting and therefore hypermethylation.

In order to quantitate the difference in DNA methylation, the assay above was carried out using
qRT‐PCR. Ct values from the HpaII amplifications can be normalized to EcoRI CT values (which
shouldn’t digest the DNA at all) to determine percentage of methylation. Results from this
normalization are shown in the bar graph below suggesting ~20% of the time F8a is methylated
at this region on the maternal allele while paternal inheritance retains <1% methylation (Figure
33).
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Figure 33. Quantitative RT‐PCR Methylation Assay at F8a. Neonatal whole brain Xm and Xp
genomic DNA was cut with HpaII or EcoRI and primers were used to amplify a region containing
3 HpaII and 0 EcoRI sites in F8a. HpaII Ct cycles (test) were normalized to the EcoRI Ct cycles
(control) to determine % efficiency of cutting. Error bars represent 95% confidence.

To further assess and vet the extent of methylation differences seen between the Xm and Xp
alleles, DNA from neonatal mouse whole brain and neonatal fibroblast were subject to sodium
bisulfite sequencing. The results are illustrated below in “lollipop” format where filled in circles
represent methylated CpGs and blank circles are unmethylated CpGs. The region assayed spans
the ZFP57 and CTCF sites shown in Figure 32 on the previous page.
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Figure 34. Bisulfite Sequencing of Xm and Xp Neonatal Brain and Fibroblast. CpG “lollipop”
diagram showing percentage of clones that were methylated in monosomic Xm and Xp
neonatal whole brain and fibroblast. Filled in circles represent methylated CpG dinucleotides
while blank circles are unmethylated CpGs.

Immediately it is obvious that F8a is hypomethylated on both alleles consistent with qRT‐PCR
results. The paternal allele appears to be completely hypomethylated in neonatal whole brain;
however, the maternal allele retains a fraction of methylation (18%) consistent with the qRT‐
PCR results (~20%). This general trend is also seen in neonatal fibroblasts, however, in both
cases it is apparent that the difference in methylation is not extensive. In light of
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parent/offspring conflict theory and the fact that many imprinted genes function during
embryogenesis, it is possible that the imprint is being relieved by the time of birth. The assay
above may be indicative of a relaxing methylation/imprint considering samples were taken at
birth (P0). Earlier stages may reveal much more maternal methylation, while the paternal allele
likely remains hypomethylated.

Differential CTCF Occupancy at F8a
These results raise the question ‐ how is the DMR working to cause imprinted
expression at Xlr3b/4b/4c? Methylation can be a large factor in regulating insulator binding as is
the case with CTCF which can’t bind methylated CpGs.198 Interestingly, at least two groups have
suggested that CTCF binding is actually the cause of differential methylation as opposed to
being the consequence.199,200 To look for differential enrichment of CTCF at the DMR in F8a,
chromatin immunoprecipitation (ChIP) using antibodies to CTCF were carried out and analyzed
for presence of F8a. The results summarized in the bar graph below show significant
enrichment of CTCF on the paternal allele of F8a consistent with complete hypomethylation for
CTCF binding (Figure 35). The maternal allele, however, shows reduced CTCF binding across the
two regions assayed, presumably because of increased methylation of F8a on this allele.

75

Figure 35. Enrichment of CTCF at F8a. ChIP of CTCF at primer locations F8aI and F8aII (locations
depicted in illustration above graph) showing significant enrichment in Xp when normalized to
CTCF bound H19.

The differential CTCF bound chromatin along with differential methylation fits a traditional
model of methylation dependent binding of CTCF as seen from the Igf2/H19 imprinting
mechanism. This region in F8a has many attributes consistent with loop forming interactions
that could be involved in silencing genes in the same neighborhood as F8a, namely Xlr3b/4b/4c.
In this respect, F8a remains CTCF bound on the paternally imprinted allele while the maternal
allele allows for at least some methylation, hindering CTCF, and ultimately bringing about
activation of maternal Xlr3b/4b/4c. Additional ChIP experiments at the same regions within F8a
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show higher enrichment of the Methyl‐CpG binding protein, MeCP2, in Xm neonatal whole
brain (Figure 36). This result might be expected due to the fact that the maternal allele shows
an increase in methylation (20%) relative to the paternal allele (<1%) and MeCP2 is known to
bind methylated regions genome‐wide. In the previous chapter it was discussed that MeCP2
can recruit ATRX which is able to help deposit H3.3 within certain areas of G‐quadruplex
formation. If G‐quadruplex formation in Xlr3b/4b/4c are the cause of an RNA Polymerase II
stall, then it stands to reason that MeCP2 may be recruiting ATRX to deposit H3.3 in
Xlr3b/4b/4c to relieve G‐quadruplex formation allowing maternal Pol II read‐through. It would
be interesting to reveal recruitment of ATRX to the locus in an allele specific manner – this
would explain maternal allele activation of the surrounding imprinted Xlrs.
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Figure 36. Enrichment of MeCP2 at F8a. ChIP of MeCP2 at primer locations F8aI and F8aII
showing significant enrichment in Xm neonatal whole brain relative to Xp when normalized to
MeCP2 bound H19.
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Deletion of the Putative ICR in F8a

In order to conclusively determine whether the CpG island in F8a is an imprinting control
region, a deletion strategy was pursued using CRISPR‐Cas9 technology. In this scheme two
plasmids are used, each with a unique “guide RNA” that is homologous to a region of the
genome. These guide RNAs are cloned 5’ of a “tracr RNA” which is recognized by the Cas9
protein (Figure 37A). The Cas9 protein is therefore targeted to the tracr and guide RNAs and
cuts any proximal PAM sequence (NGG) making a double stranded break. In our case, 2 cuts
were made using 2 different guide RNAs that flank the CpG island in F8a (plasmids seen in
Appendix: Cas9+OFP+). To correct the two double strand breaks, the cell will activate the non‐
homologous end joining (NHEJ) DNA repair pathway causing a deletion of everything between
the two cut sites (Figure 37B).

A
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Figure 37. CRISPR/Cas9 Scheme Targeting F8a. A.) Depiction of CRISPR/Cas9 mechanism for
targeted deletions. B.) Location of targeted guide RNAs for deletion of the CpG island in F8a.

Neonatal male (XY) fibroblasts were cultured for transfection of the CRISPR deletion
vectors in order to remove the CpG island in F8a to assess its effect on Xlr3b expression status.
Male mice have the Xm and hence have active copies of Xlr3b/4b/4c. Deletion of F8a would be
expected to either silence Xlr3b or upregulate it if F8a acts as a local ICR (discussed further in
Synthesis chapter). Figure 38A shows successful deletion of F8a in CRISPR transfected cells
compared to WT conditions. The high deletion efficiency was achieved through FACS sorting of
the cells expressing Orange Fluorescent Protein originating from the CRISPR/Cas9 plasmids.
Cells were allowed to grow for 12 days post‐FACS sort and then analyzed for differences in
Xlr3b expression relative to control cells. Unfortunately, significant expression differences are
not apparent in this deletion assessment (Figure 38B). No significant change was seen when F8a
was deleted in Xm fibroblasts (Figure 38C) or Xp fibroblasts (data not shown). There are a
multitude of reasons an expression change wasn’t achieved and I remain hopeful that this
region is not only a DMR, but also an ICR. Perhaps the imprinting mechanism at F8a is set up
early in embryogenesis, and once established, deletion of F8a can no longer have an effect on
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the imprinted paralogs. To combat this, an F8a knockout mouse should be generated and can
be bred into the X‐monosomic breeding scheme to generate F8a deletions in Xm and Xp mice.
This would allow analysis of the DMR’s effects throughout embryogenesis. Also, with
methylation of maternal F8a tracking with active Xlr3b/4b/4c, a more appropriate experiment
may be to methylate F8a via methyltransferase targeting to look for activation of the paralogs
around it.
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Figure 38. CRISPR/Cas9 Deletion in XY Fibroblasts A.) Gel image showing successfully 800bp
deletion of the CpG island in F8a compared to control cells. B.) Displays a lack of significant
expression difference in Xlr3b across control and F8a deleted XY fibroblast cells. C.) Displays a
lack of significant expression difference in Xlr3b across control and F8a deleted Xm fibroblast
cells.
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Chapter 6: Synthesis and Future Directions

The initial aim of this dissertation was to elucidate the protein functionality of genes
within the Xlr locus with the purpose of revealing a general reason for their existence and
massive expansion in rodentia. Concurrently, efforts were made to determine how,
mechanistically, the Xlrs are subject to parent specific gene expression as was discovered by Dr.
Adam Raefski in 2005.8 The wealth of knowledge on genes displaying parental specific behavior
(genomic imprinting) implicates many in parent‐offspring conflict, a theory in which gametes
predispose certain developmental genes to be silent or expressed with the intention of
increasing individual fitness in the offspring. Insulin‐like growth factor II (Igf2) is a hallmark
example of this type of regulation, relying on one silent and one expressed allele for proper
dosage of this growth hormone in offspring.81
What about the Xlrs? One third of the active copies in the Xlr locus are paternally
silenced (Xlr3b, Xlr4b, and Xlr4c) but remain maternally expressed. Additionally, these paralogs
are members of a larger group of similar looking genes which have duplicated to form hundreds
of copies on both the X and Y chromosomes in rodentia, begging the question – What
developmental role are these multi‐copy genes playing that relies on so many copies and
additional levels of transcriptional regulation?
Dr. Paul Burgoyne and others have shown at least 4 of these Xlr superfamily proteins
(SLX, SLXL1, SLY, XLR6/SLX2) to have high expression throughout
spermatogenesis/spermiogenesis similar to their autosomal ancestor, SYCP3.3,35,44 Extensive
examination into the potential mode of function reveals close linkage of these proteins to
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expression emanating from the sex chromosomes throughout meiosis in male mice, even
potentially acting in an inter‐genomic battle for inheritance; X vs Y.4,5,28 Conflict mechanisms
have already been shown to exist in mammals as seen with t‐haplotypes in mice and could
explain the large build‐up of these antagonistic genes analogous to an X vs Y “arms‐race.”57 It
makes sense that proteins involved in such a mechanism act throughout meiosis, a critical time
in which inheritance to the next generation is eminent.
Dr. Michael O’Neill’s lab attempted to determine protein functionality of the imprinted
Xlr3b paralog by designing an antibody initially to be used for probing lysates from brain and
fibroblast, the two tissues in which the imprint was known to manifest. It was therefore
somewhat surprising not to reveal a band in these tissues but rather see a prominent band in
nuclear testis lysate. However, taking into account the expression profile of other Xlr
superfamily proteins, it soon became clear that XLR3 was also a meiotically expressed protein.
Investigation into localization revealed XLR3 associates closely with the synaptonemal complex
exclusively at the inactive X and Y chromosomes in pachytene spermatocytes. Additional work
would show close association of XLR3 with the repressed X and Y chromosomes in post‐meiotic
round spermatids adding it to the growing list of X and Y linked genes with similar behavior. To
confirm its function, an Xlr3 shRNA knockdown transgenic mouse model was produced to
eliminate XLR3 from meiosis in order to determine the exact effect it will have on gene
expression emanating from the sex chromosomes. It is ultimately proposed that XLR3 is
controlling gene expression from the X and Y chromosomes globally during meiosis, perhaps
through interaction with the synaptonemal complex.
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This protein expression profile seems to further convolute the active imprinting of Xlr3b.
The problem at hand is that the tissue in which XLR3 functions, testis, is genotypically XmY
meaning no imprint can manifest – so why imprint a protein that won’t feel the effects? Female
tissue would be directly affected by an imprint, and in fact, it was initially thought that X‐linked
imprinted genes couldn’t exist due to absent expression entirely in half of female cells ‐ a
consequence of X‐chromosome inactivation (XCI). Interestingly, XLR3 protein was shown in this
study to also localize in meiotic oocytes raising the theory that with 1 copy silent and 5 copies
active, perhaps dosage of the protein is the key reason for imprint. Duplication of multiple
paralogs is one way of ensuring “back‐up” copies in the event one copy gains deleterious
mutations or becomes imprinted ‐ further bolstering a dosage necessity.
I propose taking another perspective on the matter ‐ Xlr4b and Xlr4c are also both
imprinted paternally. This represents one third of the active Xlr4 copies in females and two
thirds of the active copies in males, which most likely results in a severe down regulation of
XLR4 protein. In this study, a custom XLR4 antibody was generated revealing prominent bands
in the cytoplasm of neonatal whole brain and fibroblast tissues, again, the two tissues that
manifest the imprint. With imprinted expression of Xlr4b/c and translation of XLR4 protein
both occurring in brain and fibroblast it seems likely that the targeting of the imprint is
intended for the Xlr4 paralogs. This would indicate that the imprinting mechanism works within
a genomic “neighborhood” which may accidently silence 1 of the Xlr3 copies along with the 2
intended Xlr4 copies. This may not affect XLR3 protein which has 5 more copies that can
express to keep this protein available to the oocyte and has no effect on the 3 active copies in
spermatocytes. Figure 39 below summarizes this conundrum.
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While the imprint may not have directly evolved to regulate XLR3 protein, the results of
the XLR3 protein analysis remains significant. Although there is no direct human ortholog to
XLR3, there does exist a distantly homologous locus sharing ~8% identity to XLR3, termed
FAM9A, FAM9B, and FAM9C. These proteins have not been studied extensively, however, a
quote from the only paper that exists on these human homologs reveals many similarities
between XLR3 and FAM9. It states, “The deduced amino acid sequence of the three novel
proteins [FAM9A/B/C] shows homology to SYCP3, a component of the synaptonemal complex
located along the paired chromosomes during meiosis. FAM9A, FAM9B, and FAM9C are
expressed exclusively in testis; their proteins are located in the nucleus, and FAM9A localizes to
the nucleolus.”201 Suffice it to say there are many similarities between this localization of
FAM9A/B/C in humans and XLR3A/B/C in mice.
Very recently, the existence of an XLR5 protein product was found and it appears to be
upregulated during prophase I of meiosis as well. It is seen localizing with the synaptonemal
complex from leptotene through pachytene.202
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Figure 39. XLR3/XLR4 Conundrum. Depiction of the effect imprinting has on the protein coding
genes at the Xlr locus. XLR3 is unaffected by the imprint in males where it localizes to the
inactive XY chromosome and only slightly affected in oocytes where 5 duplicate copies exist. A
potentially large effect would manifest in tissues where the imprint is severe and where a
protein is translated (i.e. XLR4 in brain and fibroblast).
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In keeping with the theme of a “neighborhood” imprint it is possible that the
mechanism silencing Xlr3b/4b/4c is acting regionally at XA7.2 rather than targeting individual
genes. Imprinted genes in general are known to occur in clusters and are typically subject to the
same mode of silencing or activation mechanisms as a whole. This theory breaks down slightly
when considering the bi‐allelically expressed Factor 8‐associated A (F8a) which sits in the
middle of the imprinted Xlr paralogs, however, it does make F8a an interesting candidate for
being the imprinting controlling region (ICR) at this locus. Interest in F8a came from ChIP‐seq
data on ENCODE showing a relatively large build‐up of CTCF at the 5’ end of F8a coincident with
a CpG island. This peak is dramatic because it is the only one seen in a 200kb span across the
locus. CTCF is a master regulator protein of chromatin conformation as well as an insulator
protein implicated in a long list of looping mechanisms some of which are involved in genomic
imprinting.143 This new target inspired an in‐depth search within F8a for a differentially
methylated region (DMR), which would force differential binding of CTCF and with it the
foundational evidence for a local ICR.
Dr. Ben Carone initially searched for allele‐specific differential methylation in a locus‐
wide CpG island analysis revealing no DMR but instead extreme hypermethylation of all islands
except the hypomethylated one inside F8a. Our methylation study re‐analyzed F8a for
differential methylation through use of HpaII methyl sensitive restriction enzyme digests/PCR
revealing a clear allelic difference. This difference was quantified through using qRT‐PCR
suggesting the region gained methylation in Xm brain and fibroblast at a rate of ~20% while Xp
tissues revealed a 0‐2% gain in methylation. Bisulfite sequencing of these two tissues would
reveal consistent percentages of methylation and with it a bonafide DMR. While this is
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admittedly not a strong methylation difference we wanted to determine whether it could affect
allelic enrichment of CTCF binding at this region. Allele specific ChIP of CTCF was carried out in
the same tissues resulting in a 5‐fold enrichment of CTCF occupancy on the paternal allele of
F8a vs the maternal allele. This fits with the theory that 20% methylation of F8a on the
maternal allele is “blocking” CTCF from binding while bringing about a higher occupancy on the
hypomethylated paternal allele. The retained methylation on the maternal allele is proposed to
be necessary to activate expression of neighboring genes while complete paternal
hypomethylation results in no expression of neighboring genes. It should be noted that while
CTCF appears to have a reverse correlation with methylation, it is still likely secondary and not
causing silencing but rather recruited to ensure silencing.
Consensus sequences for CTCF as well as YY1 (tethering protein) are found within this
CpG island in F8a bolstering a potential looping or insulating mechanism to regulate the Xlrs.
Additionally, three ZFP57 consensus sites, a maternal mark preserving methylation at all known
ICRs, is seen within the F8a CpG island.172,203 We proposed to delete this F8a region via
CRISPR/Cas9 technology in hopes of activating paternal Xlr3b/4b/4c or silence the maternal
Xlr3b/4b/4c. Unfortunately, deletion of this region in neonatal fibroblast cells revealed no
change in gene expression of the surrounding Xlrs. It seems a more appropriate experiment
would be to extensively methylated F8a on the paternal allele due to the fact that methylation
of F8a correlates with activation of the surrounding Xlrs as seen from the methylated maternal
allele of F8a and the expressed Xlrs around it. This can potentially be accomplished through TAL
or CRISPR targeting of a methyltransferase specifically to F8a. The mechanisms shown in Figure
40 provides a potential mode for silencing the paternal allele through CTCF binding and
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activation of the maternal allele through methylation retention. In this model, 20% of Xm
derived cells retain methylation (likely through ZFP57 protection) of the CpG island in F8a
during development which hinder CTCF binding and abolishes CTCF insulator activity. The
methylated CpGs in F8a are therefore able to recruit a methyl‐binding domain protein MeCP2.
MeCP2 has recently been shown to recruit ATRX a DNA helicase with chromatin remodeling
abilities.171 ATRX is known to aid in deposition of the histone variant H3.3 at telemetric
sequences to allow for stabilization of regions with high G‐quadruplex complexes.169 G‐
quadruplexes result when 4 di‐guanosine residues associate with each other in a complex when
the DNA is opened up for RNA PolII transcription.204 H3.3 deposition prevents these complexes
from forming presumably allowing PolII to successfully transit the region. Therefore the
methylated maternal F8a allele recruits MeCP2 which in turn recruits ATRX which is able to
deposit H3.3 at points of G‐quadruplex formation in Xlr3b/4b/4c allowing RNA PolII to read
through to the end of the gene. All cells in Xp derived tissues retain hypomethylation of F8a and
therefore CTCF insulates the region to ensure no methylation can occur. With blockage of
methylation on the paternal allele of F8a, factors such as MeCP2 and ATRX can’t be recruited
and G‐quadruplex formation in the Xlrs may be causing an RNA PolII stall in the absence of H3.3
deposition. It should be noted that Xm tissues also display hypomethylation of F8a 80% of the
time which may reflect the imprint only manifesting in a certain cell type or possibly F8a is
acting as a metastable epi‐allele, meaning methylation is dependent on environmental effects
on the cell.205 Additionally, metastable epi‐alleles gain methylation marks prior to gastrulation
and not in the sperm and egg which fits with publications showing no significant methylation of
F8a in gametes but increased (~10‐40%) methylation from blastocyst onwards.206
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Figure 41 below was generated from the following website
(http://bioinformatics.ramapo.edu/QGRS/analyze.php) which predicts G‐quadruplex formation
in genes. Intron 6 in Xlr3b/4b/4c is a strong candidate for G4 formation as seen by the intensity
of the peaks in that region. It should be noted that while Xlr3b only retains about ~35%
homology to Xlr4b/4c, this particular region in Intron 6 is 99% identical at the nucleotide level
between the paralogs, and therefore acts as a common region for G4 formation in all imprinted
Xlrs. F8a may be able to relieve this affect in the 3 adjacent paralogs due to its proximity to
Xlr3b/4b/4c. This region is also consistent with where the RNA PolII stall may be occurring. Data
from Dr. Sohaib Qureshi and Dr. Seth Kasowitz reveals a potential RNA PolII stall somewhere
between Exon 3 and Intron 7 of Xlr3b making this Intron 6 region a strong candidate. One can’t
ignore the strong build‐up of G4 formation at the 5’ end of Xlr3b/4b/4c genes. This is in fact a
common feature seen at the origins of most genes; however, according to Bartholdy et al there
is no correlation between G4 forming sequences at promoters and initiation efficiency.166
Interestingly, F8a is well conserved throughout eutherian mammals as well as
marsupials even existing in 3 copies on the human X chromosome. While the protein product of
F8a (HAP40) is involved in binding the Huntingtin protein (Huntington’s disease) it is also
possible that the CpG island in F8a is acting as a control region for surrounding genes in human
as well.196 One of these F8a copies sits directly adjacent to Trimethyllysine Hydroxylase Epsilon
(TMLHE) a gene implicated in autism spectrum disorder (ASD). TMLHE acts in the first steps of
carnitine biosynthesis, which is essential for fatty acid transport into the mitochondria. It stands
to reason that if F8a is able to control surrounding gene expression profiles, then perhaps mis‐

90

regulation of TMLHE can lead to increased oxidative stress in the brain at critical time points
during development, ultimately caused by F8a methylation status.207–209
In conclusion, F8a is a strong candidate for being the imprinting control region for Xlr3b,
Xlr4b, and Xlr4c. It should be noted, however, that this DMR does not act like a typical DMR in
that it doesn’t display complete allelic hypermethylation vs hypomethylation. Instead, F8a
appears to retain a certain percentage of maternal methylation at F8a on a cell by cell basis,
potentially based on environmental cues.
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Figure 40. Model of the Xlr3b/4b/4c Imprinting Mechanism. In XmO neonatal brain and
fibroblast methylation is gained in 20% of cells blocking CTCF binding and allowing recruitment
of MeCP2 as well as ATRX to deposit H3.3 to allow PolII to read‐through G‐quadruplex forming
regions. Lack of methylation on the paternal allele causes insulation of CTCF and therefore no
mechanism to relieve G‐quadruplexes which ultimately causes a PolII stall.
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Figure 41. Prediction of G‐quadruplexes in Xlr3b/4b/4c. Illustration from a g‐quadruplex
prediction software indicating G4 complexes potentially present in Intron 6 of all imprinted
paralogs.
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Chapter 7: Materials and Methods, Appendices

Generation of X Monosomic Mice
39, Xm mice were produced by mating C57BL/6J females to C3H/Paf males which generates
X(m) monosomic females at a rate of 25% in each litter due to non‐disjunction of the Paf X
chromosome. 39, Xp mice were produced by crossing C3H/InX1h females to C57BL/6J males
which generates X(p) monosomic females at a rate of 20% in each litter also due to non‐
disjunction in meiosis of the InXh1 chromosome. Genotyping utilizes the DXMit130 PCR primers
which are able to distinguish the C57 and C3H X chromosomes, as well as an Smcy primer set to
distinguish the males.

Mice and Spermatogenesis Sample Collection
Animal procedures were conducted in accordance with the ethical guidelines and standards of
the SSR (The Society for the Study of Reproduction). For sample collection, testis were dissected
from C57BL/J6 or C3H/HeJ male mice (Jackson Labs) ranging from 5.5 to 18.5 days old. One
teste from each mouse was kept for protein analysis and the other for RNA analysis.

Antibody Production and Western Blot Analysis
A peptide (MSSRKRKATDTAGRHSRM [amino acids 1‐18]) was identified to be specific to
XLR3A, XLR3B, and having 1 amino acid difference from XLR3C. Synthesis of peptide and
immunizations were conducted by Biosynthesis Inc. Two rabbits were immunized followed by
five boosters every two weeks as part of the First Class Polyclonal Antibody Package. Total IgG
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sera from each mouse was affinity purified on an AminoLink (Thermo) resin column containing
immobilized peptide (Biosynthesis Inc.). The antibodies were complemented with pre‐immune
sera from each rabbit.
Testis lysate was subject to a dounce homogenizer for separation of nuclear and
cytoplasmic fractions in Harvest Buffer (10mM HEPES pH7.9, 25mM KCl, 2M Sucrose, 1mM
EDTA, 0.5mM Spermidine, 1x Protease Inhibitor, 10% Glycerol). Lysates were then
resuspended in 2x SDS sample buffer (2%SDS, 25% Glycerol, 0.06M Tris pH 6.8, 0.01%
bromophenol blue, and 5% BME) and denatured for 10 min at 95°C. Ten microliters of sample
was electrophoresed through a 12% SDS‐polyacrylamide gel at 200V for 50 min. Protein was
transferred to Immobilon‐P PVDF membrane (millipore) at 15V for 30 min. The membrane was
blocked (PBS containing 5% milk powder) for 1h at room temperature and then incubated with
primary antibody diluted in blocking solution overnight at 4°C (rabbit anti‐XLR3, 1:2000; mouse
anti‐γH2AX, 1:1000 [ab18311; abcam]; rabbit anti‐αTUBULIN, 1:40,000 [ab15246; abcam]).
Membranes were then washed 3 three times in PBS containing 0.1% Tween before incubating
in the respective secondary antibody peroxidase conjugates for 45 min (anti‐rabbit IgG HRP
1:2000 [ab6721; abcam]; anti‐mouse IgG HRP 1:100 [32430; Thermo]). After washing the
membrane three times (PBS containing 0.1% Tween), signal was detected via
chemiluminescence (Western Lightening, Perkin Elmer) on autoradiography film.

Spermatocyte and Oocyte Surface‐Spreads
Testis were dissected from three month old males and placed in PBS (MP Biomedicals)
for removal of the tunica albuginea. Approximately 25mg of seminiferous tubule was
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transferred to 1 mL of cold PBS in a petri dish, chopped up using a blade, and transferred to a
round‐bottomed tube. Five milliliters of fixative solution (2.6mM sucrose, 2%
paraformaldehyde) were added to the cells drop by drop then tubes were swirled to mix. Cells
were incubated at room temperature for 5 min and then centrifuged (1,200 rpm, 8 min). The
fixative was removed and the cells were resuspended in twenty drops of PBS. Two drops were
spread onto Superfrost Plus slides (Fisher) and air dried for 5 min. Cells were then
permeabilized by adding 0.5% Triton X‐100 onto the slides for 10 min. Slides were washed twice
in PBS and stored at ‐20°C until further use. For oocyte spreads, ovaries were dissected from
E15‐18 dpc (days post coitum) embryos (~10 ovaries per prep) and prepared using the same
protocol as spermatocytes.

Immunofluorescence and Chromosome Paints
Surface spread slides were blocked (5% goat serum in PBS) for 1h at 4°C. Slides were
rinsed in PBS (MP Biomedicals) and then incubated in primary antibody overnight at 4°C (rabbit
anti‐XLR3 1:20; mouse anti‐SYCP3 1:200 [sc74569; Santa Cruz]; mouse anti‐γH2AX 1:200
[ab18311; abcam]). After three PBS washes, slides were incubated in fluorescent secondary
antibodies diluted in PBS for 30 min at 4°C: Alexa Fluor 488‐conjugated goat anti‐rabbit 1:200
[A11034, Invitrogen]; Alexa Fluor 568‐conjugated goat anti‐mouse 1:200 [A11004, Invitrogen].
After washing three times in PBS, slides were dried and DAPI (4'6'‐diamidino‐2‐phenylindole,
Vector Labs) diluted in mounting media was applied using a cover slip. DAPI was not applied to
slides subject to chromosome paints, instead these slides were fixed in 4%
paraformaldehyde/0.5% Triton X‐100 for 10 min followed by fixation in 3:1 methanol:acetic
96

acid for 15 min. These slides were aged overnight at room temperature in the dark. Ten
microliters of mouse X (XMP D‐1420‐050; Metasystems) or Y (YMP D‐1421‐050, Metasystems)
chromosome paints labeled with either Texas Red or FITC wavelength emitting fluorophores
were applied to the aged slide, and the probe/slide were simultaneously denatured at 75°C for
8‐10 minutes before incubating at 37°C in a humid chamber overnight. The slide was then
washed in 0.4x SSC at 72°C for 2 min followed by a 30s rinse in room temperature 2x SSC. After
drying DAPI was added in mounting media using a cover slip.

Microscopy
All pictures were taken with the 100x objective lens using an Olympus IX 71 (Delta Vision)
microscope. This scope is equipped with cubes that excite Texas Red, FITC, and DAPI
fluorophores. Pictures were taken at focal lengths in which the target signal was in focus.

RNA Isolation and qRT‐PCR
Total RNA from testis was isolated using TRIzol reagent (Invitrogen) as described by the
supplier's instructions. One microgram of total RNA was reverse transcribed using Oligo dT and
random primers (qScript; Quanta) in a 20‐uL reaction as described by the supplier's instructions.
0.5‐uL of cDNA template was added to a 15‐uL reaction with Sybr Green (Bio‐Rad). Reactions
were cycled using an iCycler (Bio‐Rad) for 40 cycles. Resulting CT values were normalized to the
control gene b‐actin using ΔΔCt method.
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Vector Transfection in Cell Culture
The vector used to generate the knockdown, eGFP‐shXLR3 (5.3 Kb) and eGFP‐empty (5.2Kb),
were transfected into WT C57BL/6J neonatal fibroblasts via Invitrogen's Neon Transfection
System. The system applies a predetermined electric pulse allowing ~90% transfection
efficiency. eGFP was used as a selectable marker for sorting via Fluorescence‐Activated Cell
Sorting (FACs), followed by RNA extraction of the control and knockdown samples. This RNA
was converted into cDNA and qRT‐PCR was carried out as discussed previously using B‐actin for
control expression.

Chromatin Immunopreciptiation
ChIP was conducted on X monosomic (39, Xm/Xp) neonatal female whole brain and fibroblast
using the MAGnify Chromatin Immunoprecipitation System from Invitrogen (49‐2024). Briefly,
samples were fixed in a suspension containing 1% formaldehyde for 10 minutes prior to cell
lysis. Chromatin was then sheared down to 100‐300bp size range using the Covaris S2
sonicating water bath. Next, protein A/G beads were coupled with 1‐3ug of the antibody of
choice for 12‐16hr (i.e. anti‐CTCF ‐ ab70303), a control reaction containing 1ug of rabbit IgG was
included. 25ug of the fixed and fragmented chromatin was incubated with this bead/antibody
complex at 4°C for 12‐16hr. After post‐ChIP washes, crosslinks were reversed with Proteinase K
at 55°C for 15 min. The remaining DNA was purified again and then eluted off the beads in 30uL
of elution buffer and stored at ‐20°C. Primers were designed for CTCF control and target regions
and analyzed through qPCR.
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Bisulfite Sequencing
Genomic DNA was extracted from X monosomic mice (39, Xm/Xp) and converted using Zymo's
EZ DNA Methylation Kit (D5001). ~500ng of DNA was denatured and incubated with a "CT
conversion" reagent for 16 hours at 50°C. After a column clean‐up the template can be
amplified using primers that will bind CT converted sequence (Zymo ‐ Bisulfite Primer Sequence
tool). Primer sequences can be found in the Supplemental tables.
Hpa II Methylation Sensitive Assay
Xm and Xp neonatal whole brain genomic DNA was digested with the methyl sensitive restriction
enzyme HpaII and separately EcoRI (control). Primers (F8a1F and F8a1R) flanking the region of
interest were used to amplify the digested DNA revealing a band if HpaII didn’t cut
(methylation). No band results in sufficient cutting of HpaII at 1 or more sites within the
amplicon indicating hypomethylation. In order to quantify the level of methylation, the same
experiment was run via qRT‐PCR and normalized to EcoRI.
CRISPR/Cas9
Target guide RNAs were designed to flank the CpG island in F8a ensuring that the required PAM
sequence (NGG) exists downstream for proper Cas9 cutting. The 2 guide RNAs (see Appendix)
were cloned into the same type of episomal vector [Cas9(+) OFP(+)] (Life Tech) allowing for
fluorescent sorting of cells exclusively containing both guide RNAs. 1ug of these two plasmids
was transfected into mouse neonatal fibroblasts via Invitrogen’s Neon system per
manufacturer’s protocol. Both vectors carry the Cas9 protein CDS while allowing for high
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transcription of the respective guide RNAs. After transfection, the cells were fluorescently
sorted too confirm a deletion.

100

Appendix
Primer
Xlr3abcde F
Xlr3abcde R
Actb F
Actb R
MIT130 F
MIT130 R
SMCY F
SMCY R
M13 F
M13 R
Xlr3b Imp F
Xlr3b Imp R
F8a F1
F8a R1
F8a F2
F8a R2
H19 F
H19 R
BS F8A F
BS F8A R
Xlr3sh F
Xlr3sh R
F8a 5’ guide
F8a 3’ guide
F8a Deletion F
F8a Deletion R

Sequence (5'‐3')
AAAGGAAGGCCACTGACAC
TGTTGCCTCTCTGTTCCTGA
ACACCCGCCACCAGTTCG
CGATGGAGGGGAATACAGCC
TTCATATCGCCCCAACCTAC
TATTTTGAAACCTCTGCCATTT
TGAACTGCCTGCTATGCTAC
GCCTCAGATTCCAATGCTC
CAGGAAACAGCTATGAC
GTAAAACGACGGCCAG
AGGCTGCCTTGTGGAGAG
TGTCAGTGGCCTTCCTTTTT
CCAGGAGTGCCTGCCTTAT
CTGCAGAGGCTCCCCGTA
CTGCACTGTGCCTGGAACTA
GCGTTGCATGCGTGTAAATA
AACCGCCAACAAGAAAGTCTGG
GCTTCGGACATTGCTGTGGG
GGGGAAGYGTTGGTTTTTATAGAGG
AACAATACACRAAACACCTCACACCTAACTAAAAC
GAGAGGCAACAGGCCAGGAAGGAAAGAAGCTTGTTTCCTTCCTGGCCTGTTGCCTCTCTTTTT
AAAAAGAGAGGCAACAGGCCAGGAAGGAAACAAGCTTCTTTCCTTCCTGGCCTGTTGCCTCTC
CTTCTTGGCACGCTATCGGC
GGCTCTGTTGCGCCTTCACC
GTCATAGCTGTTCCCCCTCA
AGTCAGGTGTGAGGTGTCCC

Addgene
Plasmids
pEGFP‐N1
Cas9(+)OFP(+)
ROSA26‐PAS

Description
Expression vector with GFP cassette
Contains Cas9, OFP selection and site to clone guide RNA in front of Tracer RNA
ROSA locus recombination vector with 5' and 3' arms
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Antibody
Mouse anti‐γH2AX
Rabbit anti‐αTubulin
Rabbit anti‐XLR3
Rabbit anti‐XLR4
Mouse anti‐SYCP3
Rabbit (polyclonal) anti‐CTCF
Rabbit anti‐SYCP3
Rabbit anti‐Fibrillarin
Rabbit anti‐MeCP2

Supplier
Abcam
Abcam
Biosynthesis Inc.
GenScript
Santa Cruz
Abcam
Abcam
Abcam
Abcam

Cat #
ab18311
ab15246
Peptide: MSSRKRKATDTAGRHSRM
Peptide: MASKIKGRPPKQPKC
sc74569
ab70303
ab15092
ab5821
ab2828

U6‐Xlr3sh‐eGFP
CMV 11..586

GFP 641..1356
Xlr3-sh 4219..4281
pEGFP-N1-XLR3shRNA
U6 3816..4214

5333 bp
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Cas9(+)OFP(+)
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Xlr3sh‐ROSA26PAS
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